
Citation: Renata Tisi, Marco Rigamonti, Silvia Groppi, Fiorella Belotti. Calcium homeostasis and signaling in fungi and their relevance for pathogenicity of yeasts and filamentous fungi[J]. AIMS Molecular Science, 2016, 3(4): 505-549. doi: 10.3934/molsci.2016.4.505
[1] | Geovanni Alberto Ruiz-Romero, Carolina Álvarez-Delgado . Effects of estrogens in mitochondria: An approach to type 2 diabetes. AIMS Molecular Science, 2024, 11(1): 72-98. doi: 10.3934/molsci.2024006 |
[2] | Shizuka Takaku, Naoko Niimi, Toshihiko Kadoya, Hideji Yako, Masami Tsukamoto, Kunihiko Sakumi, Yusaku Nakabeppu, Hidenori Horie, Kazunori Sango . Galectin-1 and galectin-3 as key molecules for peripheral nerve degeneration and regeneration. AIMS Molecular Science, 2016, 3(3): 325-337. doi: 10.3934/molsci.2016.3.325 |
[3] | Archana M Navale, Vanila Devangan, Arpit Goswami, Vikas Sahu, Lavanya S, Devanshu Patel . Effects of pre-existing metformin therapy on platelet count, serum creatinine, and hospitalization in COVID-19 patients with diabetes mellitus. AIMS Molecular Science, 2023, 10(4): 311-321. doi: 10.3934/molsci.2023018 |
[4] | Afreen Bhatty, Zile Rubab, Hafiz Syed Mohammad Osama Jafri, Sheh Zano . Identification of dysregulated pathways through SLC30A8 protein interaction in type 1 diabetes mellitus. AIMS Molecular Science, 2021, 8(4): 301-310. doi: 10.3934/molsci.2021023 |
[5] | Joanne L. Hopper, Natasha Begum, Laura Smith, Thomas A. Hughes . The role of PSMD9 in human disease: future clinical and therapeutic implications. AIMS Molecular Science, 2015, 2(4): 476-484. doi: 10.3934/molsci.2015.4.476 |
[6] | J.R. Calvo, M.D. Maldonado . The role of melatonin in autoimmune and atopic diseases. AIMS Molecular Science, 2016, 3(2): 158-186. doi: 10.3934/molsci.2016.2.158 |
[7] | Mohamad S. Hakim, Xinying Zhou, Yijin Wang, Maikel P. Peppelenbosch, Qiuwei Pan . Anti-diabetic drugs, insulin and metformin, have no direct interaction with hepatitis C virus infection or anti-viral interferon response. AIMS Molecular Science, 2014, 1(1): 49-58. doi: 10.3934/molsci.2014.1.49 |
[8] | Yu Sato, Hiroyuki Jinnouchi, Atsushi Sakamoto, Anne Cornelissen, Masayuki Mori, Rika Kawakami, Kenji Kawai, Renu Virmani, Aloke V. Finn . Calcification in human vessels and valves: from pathological point of view. AIMS Molecular Science, 2020, 7(3): 183-210. doi: 10.3934/molsci.2020009 |
[9] | Rahel Tekeste, Gregorio Garza, Song Han, Jianli Dong . Ticagrelor is more effective than clopidogrel in carrier of nonfunctional CYP2C19 allele who has diabetes and acute coronary syndrome - case report and literature review. AIMS Molecular Science, 2022, 9(2): 66-78. doi: 10.3934/molsci.2022004 |
[10] | William A. Toscano, Jr., Hitakshi Sehgal, Emily Yang, Lindsey Spaude, A. Frank Bettmann . Environment-Gene interaction in common complex diseases: New approaches. AIMS Molecular Science, 2014, 1(4): 126-140. doi: 10.3934/molsci.2014.4.126 |
Metabolic disorders (MD), including T1DM and type 2 diabetes mellitus (TIIDM) affect approximately about 35% of the world populations. Autoimmune dysfunction is the foremost major mechanism that produces T1DM by destroying β-cells, which produces insulin and maintains homeostasis of blood glucose levels all over the body. Insufficient or loss of insulin secretion leads to hyperglycemia as well as acidosis. These metabolic and/or diabetic disorders are associated with the alterations of either or both catecholamine's and protein kinases [1]–[9] particularly in T1DM. Dysfunction of neurotransmitter is the most and well documented effects of diabetes mellitus on central nervous system (CNS) [5]–[13] and accompanied by a number of CNS abnormalities including neuronal atrophy and axonal degenerations [7],[14],[15].
We have shown that the Ca2+-dependent-phorbol esters sensitive,-and a family of serine/threonine (CPST) protein kinases such as protein kinase C-alpha (PKC-α) [5],[6],[10], Ca2+/calmodulin-dependent protein kinase II (CaMKII) [5],[6],[11] and p38-mitogen activated protein kinase (p38 MAPK) [4]–[6],[13] were altered during T1DM, NDH and NDA condition(s) (Figure 1), correlating with the changes of neurotransmitters in discrete areas of brain. These changes were reversed to normal either after insulin or with respective pharmacological-suppressor's treatments. MAPK activates/mediates many of the cellular and molecular functions in response to CPST-induced signals, including neurotransmitters synthesis and release [7],[9],[16]–[19].
p38 MAPK and neurotransmitters [5]–[7],[17]–[19] plays crucial roles on various molecules and triggers its functions and ultimately leads to various complications under T1DM. Thus, it is very important to maintain these molecules under control either by insulin or any pharmacological agents which regulates these elements to prevent the progress of diabetic complications, including diabetes-mediated heart failure (DMHF).
In this review, we are discussing p38 MAPK, 5-hydroxytryptamine (5-HT), dopamine (DA) and epinephrine (E) in seven areas of brain viz. Striatum (ST), Hippocampus (HC), Hypothalamus (HT), Midbrain (MB), Pons Medulla (PM), Cerebellum (CB) and Cerebral Cortex (CCX). Studies have shown that the alterations of p38 MAPK correlated with the changes of DA, E and 5-HT [4]–[7],[13],[17]–[19] in some specific areas of brain, suggesting that p38 MAPK may regulate the level and functions of DA, E and 5-HT, in respective areas, under diabetic condition. The pharmacological-suppressor of p38 MAPK as well as insulin normalized these changes.
Hyperglycemia and/or acidosis mediated CVDs are the major cause of death in DMHF [20]–[23]. Insulin regulates glucose homeostasis and mediates several physiological functions. However, in contrast, the complete or significant reversal of these signal molecules by sufficient insulin or pharmacological agents has also shown to affect some of the biochemical as well as physiological processes in the CNS and DMHF [21]–[24]. Hence, complete understanding of these mechanisms would potentially provide new targets in the treatment of DMHF.
Among all, the loss or inadequate β-cell secretion of insulin develops variety of risk factors including hyperglycemia, which in turn leads to obesity, increased blood triglycerides, acidosis. All these changes either alone or in combination with other molecule(s) develops functional and structural changes of brain and neurodegeneration, [7],[14],[15] leading to abnormal functions of CNS as well as CVDs including cardiomyopathy [25] and DMHF [21]–[24],[26].
Uncontrolled diabetes has shown to develop atrophy, particularly in the brain regions [7],[14],[15]. The understandings of underlying molecular mechanisms involved in the development of atrophy and chronic cellular damage in the CNS or DMHF are limited. However, there are several reports that points in the same direction that an over or less insulin secretion and its abnormal biological functions, metabolic or mitochondrial dysfunction, oxidative stress, formation of glycation end products, increase in neurotransmitters [9],[20]–[23],[26] and activated protein kinase C (PKC) [27]–[29] or p38 MAPK [24],[30],[31] are all shown to be involved in this complex mechanisms.
p38 MAPKs are one of the main signal transduction mechanisms and the activation of which results in several cellular and molecular functions [139]. So far there are four p38 MAPK isoforms were characterized in mammalian cells: (1) p38α MAPK14, (2) p38β MAPK11, (3) p38γ MAPK12, and (4) p38δ MAPK13 [140] encoded by different genes. p38α was the first and most studied isoform, which refers to p38 MAPK in the literature. All of them are widely expressed in variety of cells and tissues at different concentrations [141].
p38 MAPKs are strongly activated by various stimulants including T1DM [4]–[6],[13]. All p38 MAPKs are CPST, which catalyze the reversible phosphorylation of proteins. The activation of these p38 MAPK isoforms (p38α, p38γ, p38β, and p38δ) are regulated by the selective and synchronized action of two kinases such as MKK3 and MKK6 [142]. These two kinases are in turn activated by a MAPK kinase kinase (MAP3K) upon phosphorylation of Serine/Threonine residues [140]. Based on sequence homology, substrate specificities, and sensitivity to chemical inhibitors, the p38 MAPK family can be further divided into two subsets, p38α/p38β and p38γ/p38δ. However, all these isoforms shares highly similar protein sequences with each other. p38δ MAPK shares 61%, 59%, and 65% amino acid identity to p38α,-β,and –γ MAPKs, respectively [143].
Expression level of p38δ MAPK directly proportional to pancreatic-β-cell death and are afforded protection against insulin resistance induced by a high-fat diet, implicating a role in the pathogenesis of diabetes mellitus [144]. p38α and p38β MAPK signaling, functions, and substrates are highly sensitive to inhibition by SB203580, SB202190, and L-167307 [145]–[147]. These compounds ultimately lead to reversal of T1DM mediated alterations of neurotransmitters [13] as well as CVD including heart failure [6]. Cardiomyocyte formation was impaired in p38γ MAPK knockdown mice [148] and both p38γ and p38δ promote cardiac hypertrophy via mTOR pathway [149]. Studies have shown that the alterations of p38 MAPK correlated with the changes of DA, E and 5-HT [4]–[7],[13],[17]–[19] in some specific areas of brain, suggesting that p38 MAPK may regulate the level and functions of DA, E and 5-HT, in respective areas, under diabetic condition (Figure 1 & 2). The pharmacological-suppressor of p38 MAPK normalized these changes suggesting a role for p38 MAPKs under diabetic conditions.
Hyperglycemia induced activation of PKC triggers the activation of p38 MAPK, which plays significant roles in insulitis [28],[32],[33]. Prolonged hyperglycemic and acidotic conditions results in insulin or drug resistance, and activation of p38 MAPK and regulation of monoamines [4],[7],[9],[13],[17]–[19],[28],[29] (Figure 1) in some specific areas of brain. Therefore, these factors either alone or in combination with one or more compounds may develop neurodegeneration, functional and structural changes of brain [7],[25],[34],[35], culminating in neurotransmitters and CNS dysfunction [17]–[19], arterial and vascular abnormalities via p38 MAPK and that may lead to CVDs and DMHF [21]–[23]. Hence, the abnormal levels observed in various signal molecules under both T1DM and NDH conditions (Figure 1) may share a common pathway by which all the intra-and extracellular changes occur.
Insulin receptor substrate-1(IRS-1) plays a key role in insulin signal transduction, and glucose transporter type-4 (GLUT-4)/(SLC2A4) gene, which is important for insulin-mediated glucose uptake [33],[36],[37]. More specifically, p38 MAPK family of protein kinases has shown to involve in the development of insulin resistance by binding to potential MAP kinase phosphorylation sites in IRS-1 [30],[31],[33],[38],[39]. Furthermore, insulin stimulation in various cell types is capable of activating members of the MAP kinase family (Figure 2), particularly Erk 1/2, JNK, and p38 [40]–[45].
p38 MAPKs activation occurs (signaling mechanisms) by dual phosphorylation of tyrosine and threonine residues, which is located in the kinase sub domain VIII. It is catalyzed by the dual specificity kinases (MKK3 or MKK6 and MAP2Ks), which are in turn activated upon phosphorylation of both serine/threonine residues and a MAP3K. This sequence of action is responsible for activating the p38MAPK pathways. This p38 MAPK activation is clearly cell type and stimulus specific. There are several MAP3Ks have shown to regulate p38MAPK signaling pathways such as mixed-lineage kinases (MLKs), thousand and one amino acid (TAO) 1 and 2, apoptosis signal-regulating kinase-1 (ASK1), TGFβ-activated kinase-1 (TAK1), and some of the MAPK/ERK kinase kinase (MEKK) family members [150]. MKK3 and MKK6 are selectively activates p38 MAPKs, and not other MAPKs [151], by docking sequences in the amino-terminus of the MKK and p38 MAPK isoform-specific sequences in the activation loop [152]–[154]. The biological effects of p38 MAPKs are determined by the magnitude and duration of its signal transduction.
p38 MAPK activation and activity occurs by several biological and pharmacological mechanisms. T1DM or pharmacological agents such as phorbol 12-myristate 13-acetate (PMA), which activates p38 MAPK [4],[13] by phosphorylation have been shown to involve in various cellular and molecular functions including neurotransmitters [16],[17],[19] as well as CVD including heart failure [6] were reversed after inhibiting p38 MAPK by its inhibitors SB203580, SB202190, and L-167307 [145]–[147].
In a recent study, the diabetic post-infarct rat myocardium has shown an increase in the phosphorylation of the p38 MAPK and that the infarction exacerbated cardiac hypertrophy, fibrosis and collagen deposition in myocardial tissue [46]–[49]. The activated p38 MAPK has shown to be involved in hypoxia, inflammation, and other growth factors including TGF-β as well as angiotensin II [39],[50]–[52]. Pro-inflammatory regulators such as interleukin-6 (IL-6), cyclooxygenase-2 (COX-2) and CCL2 in the heart [53],[54] have also been associated with an increase in the activation/expression of p38 MAPK. Myocardial infarction (MI) induced an increase in PTEN protein expression and that pathway might contribute to the increase in cardiomyocyte apoptosis [46],[55].
Both myocardial ischemia and oxidative injury induces the activation of p38 MAPK. In cultured neonatal cardiomyocytes, over-expression of p38α MAPK reduced anti-apoptotic protein Bcl-xl expression, and p38 inhibition reduced stress-induced apoptosis [86]–[89]. In contrast, other studies have shown that p38 MAPK also involves in anti-apoptotic effects during early response to oxidative stress or anoxic preconditioning via phosphorylation of α and β-Crystallin or induction of Pim-3, respectively [90],[91]. Interestingly, p38α MAPK has a pro-apoptotic role via p53 activation, whereas p38β MAPK has a pro-survival role via inhibition of ROS formation [92]–[94]. Therefore, the apoptotic effects seen after induction of p38 MAPK in various experimental conditions may be due to p38α MAPK, which represents major functional aspects in the p38 MAPK pathway. Another study indicates that inhibition of JNK/p38 MAPK-mediated inflammation and apoptosis by ivabradine improved cardiac function in STZ-induced diabetic mice [78],[95].
The MAPK signaling pathway is present in majority of the cells and transduces extracellular signals into cytoplasm and nuclei of the cells. This pathway plays a vital role in biological functions including proliferation, differentiation, transformation, and apoptosis. Several studies have shown that pathological signals, in particular diabetic hyperglycemia, which activates this pathway. Some studies have also shown that this pathway leads to diabetic complications [155] as well as the development and progression of coronary artery disease such as fibrosis, cell hypertrophy, and migration including MI [156],[157].
There are several stimulating factors such as reactive oxygen species, inflammatory factors, diabetes (hyperglycemia), and angiotensin II, which can activate this pathway are all shown to regulate indirectly by this pathway [158]. Endothelial cells cultured and treated with increasing concentrations of glucose activate the p38 MAPK signaling pathway further [159]. These studies confirmed that this pathway might play a vital role in the pathogenesis of AMI in T1DM. The over production of inflammatory factors and chemokines in T1DM (rats and/or cells) and the differential activation of the p38 MAPK signaling pathway may be a potential mechanism of pathophysiological changes in endothelial cells and cardiac dysfunction [160].
In-vitro studies have shown that both pharmacological inhibition and/or dominant negative p38 MAPK mutant expression was able to attenuate cardiomyocyte growth in response to hypertrophic stimuli [60]–[62]. Moreover, chronic activation of p38 MAPK is sufficient to induce hypertrophy in cultured cardiomyocytes [49],[62]. It has been shown that these functions were carried out by two distinct isoforms of p38 MAPK (p38α-MAPK and p38β-MAPK) (Figure 3). Even though there is a discrepancy between in-vitro and in-vivo studies on the effects of p38α-MAPK and p38β-MAPK, over expression of active cardiac-specific MKK3 and MKK6 mice did not develop cardiomyocytes [63],[64]. However, activated MKK3 in the heart results in cardiac hypertrophy and fibrosis [65]. This discrepancy might be caused by duration of p38 MAPK activation and the developmental timing of these factors.
Cardiomyocyte (CM) death and the formation of scar tissue are accompanied by hypertrophic growth caused by pressure overload or ischemic injury, which can lead to HF and lethal arrhythmias [66],[67]. The activation of the ERK1/2/p38 MAPK pathway enhances angiotensin II-induced proliferation of cardiac fibroblast/myofibroblast (CF/MF) [56]–[58]. Once CF/MF activated, it secrete extracellular matrix (ECM) in an adaptive response to injury, which enhances cardiac repair by preventing lethal wall rupture following MI [68]–[70]. However, sustained CF/MF activation eventually leads to excessive fibrosis and ventricle wall stiffening. CFs/MFs also stimulate electrical conduction, angiogenesis, inflammation, and cardiac growth and development [71]–[78]. All these changes are either completely or at-least partially normalized by p38 MAPK inhibitor.
The diabetic cardiomyopathy is associated with cardiac inflammation, myocardial infarction, pressure overload, decreased left ventricle (LV) function, and dilated cardiomyopathy [41],[79]–[81]. Furthermore, other pro-inflammatory cytokines, such as TGF-β and IL-6 have also shown to be elevated in diabetic animal models [43],[54]. Cytokines are important elements, which regulates/attenuate myocyte contractility, via reducing systolic cytosolic calcium levels by altering sarcoplasmic reticulum function [79],[82]. Recent studies suggests that a direct role of cardiomyocytes in pro-inflammatory cytokine production [83],[84].
p38 MAPK phosphorylation inhibited by suppressor simultaneously normalized the pro-inflammatory cytokine levels such as TNF-α, TGF-β and IL1-β, and IL-6 in the cardiac tissue of diabetic animals [43],[54],[85]. Inhibition of p38 phosphorylation or activity is also accompanied by improvement of LV function, which showed impaired cardiac function and increased cytokine levels in non-diabetic, transgenic, p38-overexpressing mice [49],[80],[81],[85].
MAPK and in particular p38 MAPK pathway, play a crucial role in the development of diabetic cardiomyopathy and heart failure [21]–[23],[25]. The p38 MAPK signaling cascades modulate genes that regulate cardiomyocyte proliferation, cardiomyocyte apoptosis, cardiac hypertrophy, cardiac fibrosis, and cardiac cytokine-mediated inflammation [48],[52],[56],[89],[96]. Diabetes-induced high glucose levels, oxidative stress, ischemia, and angiotensin II [38],[39],[49],[51],[52],[97] all have shown to upregulate/phosphorylate p38 MAPK. Therefore, cardiomyopathy may be prevented by inhibiting p38 MAPK in diabetic patients.
Experimental diabetic animals, imitate the structural and cellular abnormalities of diabetic cardiomyopathy of humans [37]. Both hyperglycemia and acidosis are the hallmark of T1DM, leads to several complications including cardiac fibrosis, cardiac inflammation, and LV dysfunction, through oxidative stress, angiotensin II [48],[49],[52],[89],[98]. Enormous preclinical studies have reported the role of p38 MAPK in myocardial infarction, ischemic heart disease, and atherosclerosis [55],[96],[99]. Moreover, data from human studies demonstrated that the heart samples from patients with idiopathic dilated cardiomyopathy and ischemic heart disease the p38 MAPK was found to be activated (Table 1). Recently the SOLSTICE phase 2 trials also demonstrated that suppressing the p38 MAPK improves LV function, and myocardial infarction [100],[101]. These studies are in close agreement with animal studies, and collectively demonstrate that the p38 MAPK plays vital role in cardiovascular diseases and heart failure, and that the inhibition of p38 MAPK may be a promising therapeutic target.
MAPK signalling | Study models | Consequences/summary | |||
In-vitro | In-vivo | Ex-vivo | Humans | ||
p38 MAPK isoforms | WT-mice | Cardiac dysfunction were restored by TG DN p38α MAPK | |||
Human monocytes Eucaryotic cells | Dog Monkeys | Humans | Increased inflammatory factors, cytokines and p38β MAPK were reversed by p38 MAPK inhibitor | ||
Cardio-myocytes | p38 MAPK inhibition attenuates cardiomyocyte growth in response to hypertrophic stimuli. over-expression of p38α MAPK reduced anti-apoptotic protein Bcl-xl expression, and p38 inhibition reduced stress-induced apoptosis |
||||
SD-rats | BPS treatment inhibits p38 MAPK, TNF-α, HIF-1α, MMP-9, BNP, ANP, myocardial cell apoptosis & delays the progression of DMHF in condition heart | ||||
SFMCs HFLSs PBMCs |
MK2 inhibitors decreases the expression of immune mediated inflammatory factors | ||||
Humans | p38 MAPK was activated in human heart samples of idiopathic dilated cardiomyopathy and ischemic heart disease. Suppressing it improves LV function, and myocardial infarction. |
Notes: WT: wild type; SD: sprague dawley; SFMCs: synovial fluid mononuclear cells; HFLSs: human fibroblast like synoviocytes; PBMCs: peripheral blood mononuclear cells.
Preliminary studies with p38 MAPK-specific inhibitors showed therapeutic effects on myocardial ischemia, myocardial apoptosis, and left ventricular hypertrophy [161]; Beraprost Sodium (BPS) have shown to be a promising effects on condition heart/heart failure in animal models. BPS treatment inhibits the p38 MAPK signaling pathway including expression of inflammatory factors such as TNF-α, HIF-1α, and MMP-9. It also inhibited the expression of BNP, ANP, and myocardial cell apoptosis thereby delaying the progression of DMHF and protecting cardiac function [162]–[166].
More importantly p38 MAPK signaling pathway also involve in the protection of MI. Injury of myocardial ischemia-reperfusion occurs via oxidative stress, inflammatory response, injury of mitochondria, overload of calcium, energy imbalance, and apoptosis [167],[168]. Phosphorylated p38 MAPK further activates the downstream substrates, activation of inflammatory cells, and release of inflammatory cytokines such as TNF-alpha and IL-1 beta until apoptosis [169]. The mechanism of activation and actions may be through the inhibition of inflammatory factors including TNF-alpha and IL-1 beta, which ultimately regulate the signaling pathway of p38 MAPK [170].
Diabetic heart diseases are consequences of continuous process of several factors such as inflammatory factors, dual phosphorylation of tyrosine and threonine residues, cytokines, neurotransmitters, diabetic hyperglycemia, reactive oxygen species, chemokines, proliferation, differentiation, transformation, and apoptosis etc. Several studies in various animals and humans (both in-vitro and in-vivo) showed increased level of p38 MAPK under these conditions and reversed after the use of inhibitors such as SB203580, SB202190, and L-167307 [145]–[147],[173],[174]. Cardiac dysfunction induced by diabetic wild type (WT) mice showed increased level of p38α MAPK and were restored by TG DN p38α MAPK in diabetic heart of this mice [172]. Elevated p38 MAPK in cardiac hypertrophy, and myocardial infarction in murine model systems were attenuated by pharmacological inhibitors [173]. Inhibition of p38 MAPK in Streptozotocin (STZ)-induced diabetic male Lewis rats inhibited the increase in leukostasis and expression of iNOS [171]. Preclinical studies carried out in mammalians including dogs, monkeys (macaques and baboons) and humans showed increased level of inflammatory factors and cytokines as well as p38 MAPK (Table 1). These changes were reversed after treating with p38 MAPK inhibitor (SB203580) [174].
p38 MAPK activity and activation occurs by several pathophysiological mechanisms. T1DM or pharmacological agents such as PMA, which activates p38 MAPK in Wistar strain albino rats [4],[13] by phosphorylation have been shown to regulate neurotransmitters [10]–[13] as well as CVDs and heart failure [6]. These changes were reversed after inhibiting p38 MAPK by its inhibitors (SB203580, SB202190, and L-167307). p38β MAPK have shown to inhibit the over-expressions of inflammatory cytokines in human monocytes [145], eukaryotic cells [146] as well as in in-vivo models [147]. BPS has shown to be promising effects on condition heart/heart failure in Sprague-Dawley (SD) rats. BPS treatment inhibits the p38 MAPK signaling pathway including expression of inflammatory factors such as TNF-α, HIF-1α, and MMP-9. It also inhibited the expression of BNP, ANP, and myocardial cell apoptosis (Table 1) thereby delaying the progression of DMHF and protecting cardiac function [162]–[166].
Dopamine has been shown to control peripheral glucose metabolism in animals. Interventions such as selective dopamine reuptake inhibitor vanoxerine infusion into the nuclease accumbens (NAc) shell, deep brain stimulation (DBS) of the NAc shell and administration of central bromocriptine, that directly target the central dopamine system, modulate peripheral metabolism in rodent models [102],[103]. Additionally, human data also provide evidence in support of the central regulation of dopamine in glucose metabolism [103],[104]. The same authors also demonstrated that DBS targeting the ventral anterior limb of the internal capsule (VALIC), releases striatal dopamine, which reduces insulin requirements and increases insulin sensitivity in hepatic and peripheral of obsessive-compulsive-disorder in diabetic patients.
The human data also shows that the pharmacological suppression of dopamine synthesis in healthy subjects reduces striatal dopamine concentrations [105], which decreases peripheral insulin sensitivity. Kasper et al. [103] have reported that the direct activation of D1R+neurons in the experimental model of mice, the NAc improves glucose tolerance and insulin sensitivity. On the other hand, studies have shown the biphasic effects of bromocriptine that the low doses produce motor depression, while high doses initially produce depression and later excitation [106]–[108]. Even though there are certain methodological limitations in human models, both animal and human results (data's) points in the same direction, strongly suggesting that DA and neuronal activity regulates systemic glucose metabolism.
In the past literatures, it has been reported that the neurotransmitters including DA and 5-HT, affects multiple valves with echocardiographic features. Patients those who were taking pergolide and cabergoline (ergot-derived dopamine receptor agonists) have shown to develop significant valve regurgitation. Decarboxylation of L-DOPA yields DA (Figure 3) that act by binding to its GPCRs (D1, D2, D3, D4, D5). Over activation of β-adrenoreceptors, because of dopamine hydroxylase, in cardiac fibroblasts (Figure 3) has been shown to induce inflammatory cytokines, proliferation, and fibrotic processes. Mice cannot synthesize NE or E, in the absence of dopamine hydroxylase enzyme, and that condition leads to impaired proliferation during vascular remodeling [39],[109]–[111].
Cardiovascular (CV) complications such as orthostatic hypotension (OH) and heart failure (HF) is associated with the use of D2 receptor (D2R) agonists in the treatment of PD. Apart from central nervous system effect, dopamine agonists modulate other body functions including CV system(s). D2 receptor selectively stimulates bradycardia and lowers BP both in human and animals [106],[112],[113]. Several preclinical studies have shown that administration of bromocriptine-QR (Dopamine D2 receptor agonist) in the morning increases central dopaminergic tone and this has been linked to normal insulin sensitivity and functions as well as normal glucose metabolism. Bromocriptine-QR has shown to improve various metabolic functions in diabetic-patients as well as improvements in many surrogate markers of CV disease [113]–[115].
Circulating serotonin levels, elevates during metastatic proliferation of enterochromaffin cells (serotonin secreting cells), which causes fibrous plaques on the heart valves. Moreover, the ergot-derived dopamine agonists have also shown to have significant increase in CVDs [116],[117]. These findings suggest that these neurotransmitters may play a role in the development of certain types of CVDs. It is widely reported that these signaling molecules exert their effects by two different potential pathways such as neuronal and the vascular networks, through which it affects the target sites including heart.
5-HT perform its physiological functions via CNS as well as outside the CNS, including insulin secretion, gastrointestinal peristalsis, blood coagulation, vaso-constriction, and cardiac development [118]–[120]. There are about 14 subtypes of 5-HT receptor, however 5-HT2A, 5-HT2B, 5-HT2C receptors are implicated in heart disease. 5-HT2B activation has shown to stimulate the ERK1/2 signaling pathways in the cardiac tissues and plays a vital role in the heart development. Excess Oral or intravenous administrations of 5-HT have shown to induce heart valvular disease (Figure 3) in adult mammals [121],[122] and 5-HT2 receptor antagonist treatments reversed these effects.
Increased CNS disorders correlate with increased levels of extracellular 5-HT in diabetic patients. A comparative study with diabetic patients and animal models has shown that increased 5-HT level led to impaired heart valves. Diabetes associated depression have also shown to agammaavate coronary heart disease [78],[120]. 5-HT is found in the brain, gut, and blood platelets and it is a vasoactive substance. 5-HT performs diverse cardiophysiologic functions through the 5-HT1 receptor mediating vasodilation and the 5-HT2 receptor mediating vasoconstriction in cardiac tissues. 5-HT has also shown to be involved in the pathogenesis of cerebrovascular disorders including migraine and in the cardiovascular responses to stress [120],[123].
It is well documented that the changes in central monoamine oxidase (MAO) activity (mitochondrial enzyme), may alter the central level of one or more of these amines by inactivating several monoamines. Moreover, MAO A and B play key roles in the metabolism of neurotransmitters in the CNS. MAPK signal pathway selectively induces the activation of MAO B expression thereby suggesting that the MAPK or its pathway regulates both MAO and neurotransmitters including DA/E/5-HT (Figure 2). It has also been reported that cell culture and in-vivo studies have shown that activated MEK1/2 and ERK (MAPK) activate neurotransmitters, including dopaminergic, adrenergic and serotonergic receptors [16],[17],[19].
In contrast, it has been shown that the inhibition of p38 MAPK leads to insulitis. In general, insulin release processes involves, initially metabolism of glucose, and that leads to an increase in ATP/ADP ratio as well as an increase in the cytosolic free calcium concentration (Ca2+)i, and eventually exocytosis of insulin [19],[33],[125]. Hence, it is possible that the insulitis observed after the inhibition of p38 MAPK, may be through one of the release processes described above, and that may not be involved in the regulation of MAO or DA/E/5-HT by MAPK.
Insulin treatment to either T1DM or TIIDM is the foremost option to control all diabetic complications for the last several decades. The recent recombinant technology improved the efficiency of insulin delivery with short or long acting, including various strengths as needed. However, several lines of evidence show that the prolonged treatment of insulin leads to insulin resistance [126]–[128]. Apart from insulin treatments, the trials of oral noninsulin medicaments for diabetes mellitus have been carried out for decades in T1DM as well as TIIDM patients. At first, the efforts were taken to control the release of glucose from liver to the blood stream and as a result of this the chemical/drug (biguanides) was used successfully for controlling the peripheral glucose levels [129] including juvenile [130],[131]. Moreover, the other classes of drugs, such as amylin analogues, sodium-glucose co-transporter 2 inhibitors, thiazolidinediones, incretin-based agents as glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4, were also used and reported to be effective in the treatment of T1DM [132],[133]. However, similar to insulin, these drugs also develop drug resistance as well as some known or unknown side effects.
Numerous studies have been reported that there are several variations in the disease mechanisms of animal models and human beings including the mRNA and cDNA sequences. Simultaneous sequence homology analysis of humans and rodents has shown that only ~45–48% of insulin promoter (−600 to +1) region is matching. There are several other features including cAMP response element, CCAAT box and negative regulatory element also shows marked species specificity. More importantly, the enzymes such as pyruvate carboxylase and ATP citrate lyase, which regulates glucose metabolic pathways, are reported to be significantly different from animals and humans and as a consequence, the glucose clearance and storage varies largely between animals and humans [49],[78],[134].
Despite the differences in the mechanisms of T1DM between rodents and humans, non-obese diabetic (NOD) mice and NOD-derived recombinant congenic strains share common physiological mechanisms, which give several advantages in diabetic research [124]. Many molecules including human leukocyte antigen (HLA) class I and class II linked with human diabetes were generated in transgenic mice. Only the mice expressing HLA A2.1 allele showed development of diabetes, whereas, HLA class II transgenic mice are not able to develop diabetes. These transgenic animal models will be of useful in identifying the role of peptides and its associated pathway in diabetes and in particular antigen-specific immunotherapy [135],[136]. Other studies on gut microbiome have shown that both NOD mice and humans develop T1DM [137],[138].
In short, these experimental diabetic rats, NOD mouse or transgenic models demonstrated correlation of many key physiological functions with humans. Since, there are methodological limitations and ethics involved in human studies, these animal models would give better alternative or platform for understanding the unknown or yet to be identified molecular mechanisms involved in the development of T1DM and that may provide an excellent clue for treatment options for T1DM as well as DMHF.
In conclusion, the research and clinical data's from past several decades confirm that hyperglycemia and/or acidosis of T1DM or its associated conditions influences arterial and vascular cell functions by various biological mechanisms. Several lines of reports shows that p38 MAPK is activated in CNS and PNS under T1DM and that leads to synergistic-activation of certain neurotransmitters such as DA, E and 5-HT, and those elements trigger the cardiovascular dysfunctions, including cardiomyocyte proliferation, cardiac inflammation, myocardial infarction, cardiac fibroblast/myofibroblast and fibrosis, cardiac hypertrophy, apoptosis in the heart and cardiomyopathy, leading to heart failure and death. Moreover, many studies have linked p38 MAPK in the regulation of vascular cells permeability, ECM, contractility, micro and macro vascular diseases, angiogenesis, cytokine actions, cell growth, and leukocyte adhesions. Furthermore, CPST-pathway also involved in the up-regulation of 5-HT via S-100β and SERT (serotonin transporter) (Figure 2). Collectively, all these factors determines the levels and functions of paracrine trophic effects, cytoplasmic free calcium levels, metabolism, neuronal transmission and dendritic development, formation of the blood–brain barrier, and activation of receptors in the sensory neurons. More importantly, altered glucose homeostasis leads to changes in the glucose metabolism in CNS and PNS, and that may play crucial roles in the formation of micro or macro vascular diseases, and neuronal dysfunctions, activation of p38 MAPK as well as neurotransmitters (DA, E and 5-HT), which have been shown in the regulation of various CVDs as described above. All these factors could constitute reliable and valid pathological markers in T1DM. The pharmacological agent, which controls these factors, may have potential therapeutic value in the treatment of DMHF.
The use of p38 MAPK inhibitors or dominant negative in human CVDs, in particular DMHF should strengthen future research interest in this pathway. To date, several study/experimental models such as in-vitro, in-vivo, ex-vivo and human (Table 1) are all shown that p38 MAPKs including isoforms (α, β, γ, δ) are involved in the regulation of CVDs. However, there are several other associated factors and molecules are also involved in these complex diseases. The main limiting factors to further study on the role of p38 MAPKs on various cellular and molecular functions, which determines the development and progression of these diseases, however, are the lack of specific inhibitors and activators for respective molecules involved in this chain of events of this pathway. For example, p38 MAPK over-expression can be suppressed by various compounds such as SB203580, SB202190, L-167307 [145]–[147],[173],[174] and BPS in CVDs and shown to be a promising effect on condition heart/heart failure. These treatments not only inhibits the p38 MAPK, but also inhibits the expression of other factors in MAPK signaling pathway including inflammatory factors (TNF-α, HIF-1α, and MMP-9) and BNP, ANP and myocardial cell apoptosis [162]–[166]. The prospects of therapeutic benefit for patients with CVDs in diabetes, the search for more potent and specific inhibitors of p38 MAPK and/or its associated molecules are absolutely necessary. These may provide potential treatment for the respective conditions and diseases discussed, and may also provide the opportunity to delineate the specific role of p38 MAPK in the absence of involvement of other isoforms (α, β, γ, δ) or molecules. This will also help us to identify the role of p38 MAPK in the other diseases and ultimately the treatment options.
Moreover, it is also absolutely necessary to focus on identifying specific p38 MAPK activators. This may rule out the possible involvements of non-specific molecules during the activation process. In the future, all these may translate to the development of novel therapeutic strategies for patients with CVDs and HF. These approaches (specific inhibitors or activators) may either improve or benefit in the therapeutic regimen as well as to understand clear pathophysiological mechanisms of these elements. Based on our current knowledge and continued efforts on finding better compounds or molecules, which can target specific molecule under specific condition would be of beneficial in the treatment for CVDs in DMHF.
[1] |
Wolfe D, Pearce D (2006) Channeling studies in yeast: yeast as a model for channelopathies? Neuromolecular Med 8: 279-306. doi: 10.1385/NMM:8:3:279
![]() |
[2] |
Cui J, Kaandorp J, Ositelu O, et al. (2009) Simulating calcium influx and free calcium concentrations in yeast. Cell Calcium 45: 123-132. doi: 10.1016/j.ceca.2008.07.005
![]() |
[3] |
Ton V, Rao R (2004) Functional expression of heterologous proteins in yeast: insights into Ca2+ signaling and Ca2+-transporting ATPases. Am J Physiol Cell Physiol 287: C580-589. doi: 10.1152/ajpcell.00135.2004
![]() |
[4] | Iida H, Yagawa Y, Anraku Y (1990) Essential role for induced Ca2+ influx followed by [Ca2+]i rise in maintaining viability of yeast cells late in the mating pheromone response pathway. A study of [Ca2+]i in single Saccharomyces cerevisiae cells with imaging of fura-2. J Biol Chem 265: 13391-13399. |
[5] | Halachmi D, Eilam Y (1993) Calcium homeostasis in yeast cells exposed to high concentrations of calcium. Roles of vacuolar H+-ATPase and cellular ATP. FEBS Lett 316: 73-78. |
[6] | Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1, 11-21. |
[7] | Dunn T, Gable K, Beeler T (1994) Regulation of cellular Ca2+ by yeast vacuoles. J Biol Chem 269: 7273-7278. |
[8] |
Zelter A, Bencina M, Bowman B, et al. (2004) A comparative genomic analysis of the calcium signaling machinery in Neurospora crassa, Magnaporthe grisea, and Saccharomyces cerevisiae. Fungal Genet Biol 41: 827-841. doi: 10.1016/j.fgb.2004.05.001
![]() |
[9] |
Bencina M, Bagar T, Lah L, et al. (2009) A comparative genomic analysis of calcium and proton signaling/homeostasis in Aspergillus species. Fungal Genet Biol 46: S93-S104. doi: 10.1016/j.fgb.2008.07.019
![]() |
[10] |
Pittman JK (2011) Vacuolar Ca2+ uptake. Cell Calcium 50: 139-146. doi: 10.1016/j.ceca.2011.01.004
![]() |
[11] | Brini M, Cali T, Ottolini D, et al. (2012) Calcium pumps: why so many? Compr Physiol 2: 1045-1060. |
[12] |
Palmgren MG, Axelsen KB (1998) Evolution of P-type ATPases. Biochim Biophys Acta 1365: 37-45. doi: 10.1016/S0005-2728(98)00041-3
![]() |
[13] | Vandecaetsbeek I, Vangheluwe P, Raeymaekers L, et al. (2011) The Ca2+ pumps of the endoplasmic reticulum and Golgi apparatus. Cold Spring Harb Perspect Biol 3: 725-738. |
[14] |
He W, Hu Z (2012) The role of the Golgi-resident SPCA Ca(2)+/Mn(2)+ pump in ionic homeostasis and neural function. Neurochem Res 37: 455-468. doi: 10.1007/s11064-011-0644-6
![]() |
[15] |
Brini M, Cali T, Ottolini D, et al. (2013) The plasma membrane calcium pump in health and disease. FEBS J 280: 5385-5397. doi: 10.1111/febs.12193
![]() |
[16] |
Brini M, Carafoli E (2009) Calcium pumps in health and disease. Physiol Rev 89: 1341-1378. doi: 10.1152/physrev.00032.2008
![]() |
[17] | Cunningham K, Fink G (1994) Ca2+ transport in Saccharomyces cerevisiae. J Exp Biol 196: 157-166. |
[18] |
Bowman BJ, Draskovic M, Freitag M, et al. (2009) Structure and distribution of organelles and cellular location of calcium transporters in Neurospora crassa. Eukaryot Cell 8: 1845-1855. doi: 10.1128/EC.00174-09
![]() |
[19] |
Bowman BJ, Abreu S, Margolles-Clark E, et al. (2011) Role of four calcium transport proteins, encoded by nca-1, nca-2, nca-3, and cax, in maintaining intracellular calcium levels in Neurospora crassa. Eukaryot Cell 10: 654-661. doi: 10.1128/EC.00239-10
![]() |
[20] |
Stathopoulos A, Cyert M (1997) Calcineurin acts through the CRZ1/TCN1-encoded transcription factor to regulate gene expression in yeast. Genes Dev 11: 3432-3444. doi: 10.1101/gad.11.24.3432
![]() |
[21] |
Matheos D, Kingsbury T, Ahsan U, et al. (1997) Tcn1p/Crz1p, a calcineurin-dependent transcription factor that differentially regulates gene expression in Saccharomyces cerevisiae. Genes Dev 11: 3445-3458. doi: 10.1101/gad.11.24.3445
![]() |
[22] |
Cunningham K, Fink G (1994) Calcineurin-dependent growth control in Saccharomyces cerevisiae mutants lacking PMC1, a homolog of plasma membrane Ca2+ ATPases. J Cell Biol 124: 351-363. doi: 10.1083/jcb.124.3.351
![]() |
[23] |
Findon H, Calcagno-Pizarelli AM, Martinez JL, et al. (2010) Analysis of a novel calcium auxotrophy in Aspergillus nidulans. Fungal Genet Biol 47: 647-655. doi: 10.1016/j.fgb.2010.04.002
![]() |
[24] |
Dinamarco TM, Freitas FZ, Almeida RS, et al. (2012) Functional characterization of an Aspergillus fumigatus calcium transporter (PmcA) that is essential for fungal infection. PLoS One 7: e37591. doi: 10.1371/journal.pone.0037591
![]() |
[25] |
Jiang H, Liu F, Zhang S, et al. (2014) Putative PmrA and PmcA are important for normal growth, morphogenesis and cell wall integrity, but not for viability in Aspergillus nidulans. Microbiology 160: 2387-2395. doi: 10.1099/mic.0.080119-0
![]() |
[26] |
Fan W, Idnurm A, Breger J, et al. (2007) Eca1, a sarcoplasmic/endoplasmic reticulum Ca2+-ATPase, is involved in stress tolerance and virulence in Cryptococcus neoformans. Infect Immun 75: 3394-3405. doi: 10.1128/IAI.01977-06
![]() |
[27] |
Adamikova L, Straube A, Schulz I, et al. (2004) Calcium signaling is involved in dynein-dependent microtubule organization. Mol Biol Cell 15: 1969-1980. doi: 10.1091/mbc.E03-09-0675
![]() |
[28] |
Rudolph H, Antebi A, Fink G, et al. (1989) The yeast secretory pathway is perturbed by mutations in PMR1, a member of a Ca2+ ATPase family. Cell 58: 133-145. doi: 10.1016/0092-8674(89)90410-8
![]() |
[29] |
Antebi A, Fink G (1992) The yeast Ca2+-ATPase homologue, PMR1, is required for normal Golgi function and localizes in a novel Golgi-like distribution. Mol Biol Cell 3: 633-654. doi: 10.1091/mbc.3.6.633
![]() |
[30] |
Halachmi D, Eilam Y (1996) Elevated cytosolic free Ca2+ concentrations and massive Ca2+ accumulation within vacuoles, in yeast mutant lacking PMR1, a homolog of Ca2+ -ATPase. FEBS Lett 392: 194-200. doi: 10.1016/0014-5793(96)00799-5
![]() |
[31] |
Strayle, J, Pozzan T, Rudolph H (1999) Steady-state free Ca2+ in the yeast endoplasmic reticulum reaches only 10 microM and is mainly controlled by the secretory pathway pump pmr1. EMBO J 18: 4733-4743. doi: 10.1093/emboj/18.17.4733
![]() |
[32] |
D��rr G, Strayle J, Plemper R, et al. (1998) The medial-Golgi ion pump Pmr1 supplies the yeast secretory pathway with Ca2+ and Mn2+ required for glycosylation, sorting, and endoplasmic reticulum-associated protein degradation. Mol Biol Cell 9: 1149-1162. doi: 10.1091/mbc.9.5.1149
![]() |
[33] |
Hu Z, Bonifas JM, Beech J, et al. (2000) Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet 24: 61-65. doi: 10.1038/71701
![]() |
[34] |
Behne MJ, Tu CL, Aronchik I, et al. (2003) Human keratinocyte ATP2C1 localizes to the Golgi and controls Golgi Ca2+ stores. J Invest Dermatol 121: 688-694. doi: 10.1046/j.1523-1747.2003.12528.x
![]() |
[35] |
Cronin S, Rao R, Hampton R (2002) Cod1p/Spf1p is a P-type ATPase involved in ER function and Ca2+ homeostasis. J Cell Biol 157: 1017-1028. doi: 10.1083/jcb.200203052
![]() |
[36] |
Cronin S, Khoury A, Ferry D, et al. (2000) Regulation of HMG-CoA reductase degradation requires the P-type ATPase Cod1p/Spf1p. J Cell Biol 148: 915-924. doi: 10.1083/jcb.148.5.915
![]() |
[37] |
Vashist S, Frank CG, Jakob CA, et al. (2002) Two distinctly localized p-type ATPases collaborate to maintain organelle homeostasis required for glycoprotein processing and quality control. Mol Biol Cell 13: 3955-3966. doi: 10.1091/mbc.02-06-0090
![]() |
[38] |
Yu Q, Wang H, Xu N, et al. (2012) Spf1 strongly influences calcium homeostasis, hyphal development, biofilm formation and virulence in Candida albicans. Microbiology 158: 2272-2282. doi: 10.1099/mic.0.057232-0
![]() |
[39] |
Yu Q, Ding X, Zhang B, et al. (2013) The P-type ATPase Spf1 is required for endoplasmic reticulum functions and cell wall integrity in Candida albicans. Int J Med Microbiol 303: 257-266. doi: 10.1016/j.ijmm.2013.05.003
![]() |
[40] |
Krumpe K, Frumkin I, Herzig Y, et al. (2012) Ergosterol content specifies targeting of tail-anchored proteins to mitochondrial outer membranes. Mol Biol Cell 23: 3927-3935. doi: 10.1091/mbc.E11-12-0994
![]() |
[41] |
Cohen Y, Megyeri M, Chen OC, et al. (2013) The yeast p5 type ATPase, spf1, regulates manganese transport into the endoplasmic reticulum. PLoS One 8: e85519. doi: 10.1371/journal.pone.0085519
![]() |
[42] |
Miseta A, Kellermayer R, Aiello D, et al. (1999) The vacuolar Ca2+/H+ exchanger Vcx1p/Hum1p tightly controls cytosolic Ca2+ levels in S. cerevisiae. FEBS Lett 451: 132-136. doi: 10.1016/S0014-5793(99)00519-0
![]() |
[43] |
Cai X, Lytton J (2004) The cation/Ca2+ exchanger superfamily: phylogenetic analysis and structural implications. Mol Biol Evol 21: 1692-1703. doi: 10.1093/molbev/msh177
![]() |
[44] |
Shigaki T, Rees I, Nakhleh L, et al. (2006) Identification of three distinct phylogenetic groups of CAX cation/proton antiporters. J Mol Evol 63: 815-825. doi: 10.1007/s00239-006-0048-4
![]() |
[45] |
Pozos T, Sekler I, Cyert M (1996) The product of HUM1, a novel yeast gene, is required for vacuolar Ca2+/H+ exchange and is related to mammalian Na+/Ca2+ exchangers. Mol Cell Biol 16: 3730-3741. doi: 10.1128/MCB.16.7.3730
![]() |
[46] | Forster C, Kane P (2000) Cytosolic Ca2+ homeostasis is a constitutive function of the V-ATPase in Saccharomyces cerevisiae. J Biol Chem 275: 38245-38253. |
[47] |
Waight AB, Pedersen BP, Schlessinger A, et al. (2013) Structural basis for alternating access of a eukaryotic calcium/proton exchanger. Nature 499: 107-110. doi: 10.1038/nature12233
![]() |
[48] | Kingsbury TJ, Cunningham KW (2000) A conserved family of calcineurin regulators. Genes Dev 14: 1595-1604. |
[49] |
Spielvogel A, Findon H, Arst HN, et al. (2008) Two zinc finger transcription factors, CrzA and SltA, are involved in cation homoeostasis and detoxification in Aspergillus nidulans. Biochem J 414: 419-429. doi: 10.1042/BJ20080344
![]() |
[50] |
Kmetzsch L, Staats CC, Simon E, et al. (2010) The vacuolar Ca2+ exchanger Vcx1 is involved in calcineurin-dependent Ca2+ tolerance and virulence in Cryptococcus neoformans. Eukaryot Cell 9: 1798-1805. doi: 10.1128/EC.00114-10
![]() |
[51] |
Cagnac O, Aranda-Sicilia MN, Leterrier M, et al. (2010) Vacuolar cation/H+ antiporters of Saccharomyces cerevisiae. J Biol Chem 285: 33914-33922. doi: 10.1074/jbc.M110.116590
![]() |
[52] |
Demaegd D, Foulquier F, Colinet AS, et al. (2013) Newly characterized Golgi-localized family of proteins is involved in calcium and pH homeostasis in yeast and human cells. Proc Natl Acad Sci U S A 110: 6859-6864. doi: 10.1073/pnas.1219871110
![]() |
[53] |
Foulquier F, Amyere M, Jaeken J, et al. (2012) TMEM165 deficiency causes a congenital disorder of glycosylation. Am J Hum Genet 91: 15-26. doi: 10.1016/j.ajhg.2012.05.002
![]() |
[54] |
Cagnac O, Leterrier M, Yeager M, et al. (2007) Identification and characterization of Vnx1p, a novel type of vacuolar monovalent cation/H+ antiporter of Saccharomyces cerevisiae. J Biol Chem 282: 24284-24293. doi: 10.1074/jbc.M703116200
![]() |
[55] |
Manohar M, Mei H, Franklin AJ, et al. (2010) Zebrafish (Danio rerio) endomembrane antiporter similar to a yeast cation/H+ transporter is required for neural crest development. Biochemistry 49: 6557-6566. doi: 10.1021/bi100362k
![]() |
[56] |
Hong S, Cong X, Jing H, et al. (2013) Characterization of Ca2+/H+ exchange in the plasma membrane of Saccharomyces cerevisiae. Arch Biochem Biophys 537: 125-132. doi: 10.1016/j.abb.2013.07.005
![]() |
[57] |
Fischer M, Schnell N, Chattaway J, et al. (1997) The Saccharomyces cerevisiae CCH1 gene is involved in calcium influx and mating. FEBS Lett 419: 259-262. doi: 10.1016/S0014-5793(97)01466-X
![]() |
[58] |
Iida H, Nakamura H, Ono T, et al. (1994) MID1, a novel Saccharomyces cerevisiae gene encoding a plasma membrane protein, is required for Ca2+ influx and mating. Mol Cell Biol 14: 8259-8271. doi: 10.1128/MCB.14.12.8259
![]() |
[59] |
Martin DC, Kim H, Mackin NA, et al. (2011) New regulators of a high affinity Ca2+ influx system revealed through a genome-wide screen in yeast. J Biol Chem 286: 10744-10754. doi: 10.1074/jbc.M110.177451
![]() |
[60] |
Ding X, Yu Q, Xu N, et al. (2013) Ecm7, a regulator of HACS, functions in calcium homeostasis maintenance, oxidative stress response and hyphal development in Candida albicans. Fungal Genet Biol 57: 23-32. doi: 10.1016/j.fgb.2013.05.010
![]() |
[61] |
Tasaka Y, Nakagawa Y, Sato C, et al. (2000) yam8+, a Schizosaccharomyces pombe gene, is a potential homologue of the Saccharomyces cerevisiae MID1 gene encoding a stretch-activated Ca2+-permeable channel. Biochem Biophys Res Commun 269: 265-269. doi: 10.1006/bbrc.2000.2278
![]() |
[62] |
Lew RR, Abbas Z, Anderca MI, et al. (2008) Phenotype of a mechanosensitive channel mutant, mid-1, in a filamentous fungus, Neurospora crassa. Eukaryot Cell 7: 647-655. doi: 10.1128/EC.00411-07
![]() |
[63] |
Wang S, Cao J, Liu X, et al. (2012) Putative calcium channels CchA and MidA play the important roles in conidiation, hyphal polarity and cell wall components in Aspergillus nidulans. PLoS One 7: e46564. doi: 10.1371/journal.pone.0046564
![]() |
[64] |
Brand A, Lee K, Veses V, et al. (2009) Calcium homeostasis is required for contact-dependent helical and sinusoidal tip growth in Candida albicans hyphae. Mol Microbiol 71: 1155-1164. doi: 10.1111/j.1365-2958.2008.06592.x
![]() |
[65] |
Liu M, Du P, Heinrich G, et al. (2006) Cch1 mediates calcium entry in Cryptococcus neoformans and is essential in low-calcium environments. Eukaryot Cell 5: 1788-1796. doi: 10.1128/EC.00158-06
![]() |
[66] |
Cavinder B, Hamam A, Lew RR, et al. (2011) Mid1, a mechanosensitive calcium ion channel, affects growth, development, and ascospore discharge in the filamentous fungus Gibberella zeae. Eukaryot Cell 10: 832-841. doi: 10.1128/EC.00235-10
![]() |
[67] |
Hallen HE, Trail F (2008) The L-type calcium ion channel cch1 affects ascospore discharge and mycelial growth in the filamentous fungus Gibberella zeae (anamorph Fusarium graminearum). Eukaryot Cell 7: 415-424. doi: 10.1128/EC.00248-07
![]() |
[68] |
Bormann J, Tudzynski P (2009) Deletion of Mid1, a putative stretch-activated calcium channel in Claviceps purpurea, affects vegetative growth, cell wall synthesis and virulence. Microbiology 155: 3922-3933. doi: 10.1099/mic.0.030825-0
![]() |
[69] |
Zhou XL, Stumpf MA, Hoch HC, et al. (1991) A mechanosensitive channel in whole cells and in membrane patches of the fungus Uromyces. Science 253: 1415-1417. doi: 10.1126/science.1716786
![]() |
[70] |
Nakajima-Shimada J, Sakaguchi S, Tsuji F, et al. (2000) Ca2+ signal is generated only once in the mating pheromone response pathway in Saccharomyces cerevisiae. Cell Struct Funct 25: 125-131. doi: 10.1247/csf.25.125
![]() |
[71] |
Batiza A, Schulz T, Masson P (1996) Yeast respond to hypotonic shock with a calcium pulse. J Biol Chem 271: 23357-23362. doi: 10.1074/jbc.271.38.23357
![]() |
[72] |
Matsumoto T, Ellsmore A, Cessna S, et al. (2002) An osmotically induced cytosolic Ca2+ transient activates calcineurin signaling to mediate ion homeostasis and salt tolerance of Saccharomyces cerevisiae. J Biol Chem 277: 33075-33080. doi: 10.1074/jbc.M205037200
![]() |
[73] |
Peiter E, Fischer M, Sidaway K, et al. (2005) The Saccharomyces cerevisiae Ca2+ channel Cch1pMid1p is essential for tolerance to cold stress and iron toxicity. FEBS Lett 579: 5697-5703. doi: 10.1016/j.febslet.2005.09.058
![]() |
[74] |
Locke E, Bonilla M, Liang L, et al. (2000) A homolog of voltage-gated Ca2+ channels stimulated by depletion of secretory Ca2+ in yeast. Mol Cell Biol 20: 6686-6694. doi: 10.1128/MCB.20.18.6686-6694.2000
![]() |
[75] |
Rigamonti M, Groppi S, Belotti F, et al. (2015) Hypotonic stress-induced calcium signaling in Saccharomyces cerevisiae involves TRP-like transporters on the endoplasmic reticulum membrane. Cell Calcium 57: 57-68. doi: 10.1016/j.ceca.2014.12.003
![]() |
[76] | Courchesne WE, Vlasek C, Klukovich R, et al. (2011) Ethanol induces calcium influx via the Cch1-Mid1 transporter in Saccharomyces cerevisiae. Arch Microbiol 193: 323-334. |
[77] |
Groppi S, Belotti F, Brand?o RL, et al. (2011) Glucose-induced calcium influx in budding yeast involves a novel calcium transport system and can activate calcineurin. Cell Calcium 49: 376-386. doi: 10.1016/j.ceca.2011.03.006
![]() |
[78] |
T?k��s-F��zesi M, Bedwell D, Repa I, et al. (2002) Hexose phosphorylation and the putative calcium channel component Mid1p are required for the hexose-induced transient elevation of cytosolic calcium response in Saccharomyces cerevisiae. Mol Microbiol 44: 1299-1308. doi: 10.1046/j.1365-2958.2002.02956.x
![]() |
[79] |
Tisi R, Baldassa S, Belotti F, et al. (2002) Phospholipase C is required for glucose-induced calcium influx in budding yeast. FEBS Lett 520: 133-138. doi: 10.1016/S0014-5793(02)02806-5
![]() |
[80] |
Viladevall L, Serrano R, Ruiz A, et al. (2004) Characterization of the calcium-mediated response to alkaline stress in Saccharomyces cerevisiae. J Biol Chem 279: 43614-43624. doi: 10.1074/jbc.M403606200
![]() |
[81] | Courchesne W, Ozturk S (2003) Amiodarone induces a caffeine-inhibited, MID1-depedent rise in free cytoplasmic calcium in Saccharomyces cerevisiae. Mol Microbiol 47: 223-234. |
[82] | Muller E, Locke E, Cunningham K (2001) Differential regulation of two Ca2+ influx systems by pheromone signaling in Saccharomyces cerevisiae. Genetics 159: 1527-1538. |
[83] |
Bonilla M, Cunningham K (2003) Mitogen-activated protein kinase stimulation of Ca2+ signaling is required for survival of endoplasmic reticulum stress in yeast. Mol Biol Cell 14: 4296-4305. doi: 10.1091/mbc.E03-02-0113
![]() |
[84] |
Jiang H, Shen Y, Liu W, et al. (2014) Deletion of the putative stretch-activated ion channel Mid1 is hypervirulent in Aspergillus fumigatus. Fungal Genet Biol 62: 62-70. doi: 10.1016/j.fgb.2013.11.003
![]() |
[85] |
Paidhungat M, Garrett S (1997) A homolog of mammalian, voltage-gated calcium channels mediates yeast pheromone-stimulated Ca2+ uptake and exacerbates the cdc1(Ts) growth defect. Mol Cell Biol 17: 6339-6347. doi: 10.1128/MCB.17.11.6339
![]() |
[86] |
Hong MP, Vu K, Bautos JM, et al. (2013) Activity of the calcium channel pore Cch1 is dependent on a modulatory region of the subunit Mid1 in Cryptococcus neoformans. Eukaryot Cell 12: 142-150. doi: 10.1128/EC.00130-12
![]() |
[87] |
Wang H, Liang Y, Zhang B, et al. (2011) Alkaline stress triggers an immediate calcium fluctuation in Candida albicans mediated by Rim101p and Crz1p transcription factors. FEMS Yeast Res 11: 430-439. doi: 10.1111/j.1567-1364.2011.00730.x
![]() |
[88] | Eilam Y, Chernichovsky D (1987) Uptake of Ca2+ driven by the membrane potential in energy-depleted yeast cells. J Gen Microbiol 133: 1641-1649. |
[89] |
Eilam Y, Othman M (1990) Activation of Ca2+ influx by metabolic substrates in Saccharomyces cerevisiae: role of membrane potential and cellular ATP levels. J Gen Microbiol 136: 861-866. doi: 10.1099/00221287-136-5-861
![]() |
[90] |
Pereira M, Tisi R, Fietto L, et al. (2008) Carbonyl cyanide m-chlorophenylhydrazone induced calcium signaling and activation of plasma membrane H+-ATPase in the yeast Saccharomyces cerevisiae. FEMS Yeast Res 8: 622-630. doi: 10.1111/j.1567-1364.2008.00380.x
![]() |
[91] |
Stefan CP, Zhang N, Sokabe T, et al. (2013) Activation of an essential calcium signaling pathway in Saccharomyces cerevisiae by Kch1 and Kch2, putative low-affinity potassium transporters. Eukaryot Cell 12: 204-214. doi: 10.1128/EC.00299-12
![]() |
[92] |
Stefan CP, Cunningham KW (2013) Kch1 family proteins mediate essential responses to endoplasmic reticulum stresses in the yeasts Saccharomyces cerevisiae and Candida albicans. J Biol Chem 288: 34861-34870. doi: 10.1074/jbc.M113.508705
![]() |
[93] |
Maruoka T, Nagasoe Y, Inoue S, et al. (2002) Essential hydrophilic carboxyl-terminal regions including cysteine residues of the yeast stretch-activated calcium-permeable channel Mid1. J Biol Chem 277: 11645-11652. doi: 10.1074/jbc.M111603200
![]() |
[94] |
Possani LD, Becerril B, Delepierre M, et al. (1999) Scorpion toxins specific for Na+-channels. Eur J Biochem 264: 287-300. doi: 10.1046/j.1432-1327.1999.00625.x
![]() |
[95] |
Senatore A, Monteil A, van Minnen J, et al. (2013) NALCN ion channels have alternative selectivity filters resembling calcium channels or sodium channels. PLoS One 8: e55088. doi: 10.1371/journal.pone.0055088
![]() |
[96] | Ghezzi A, Liebeskind BJ, Thompson A, et al. (2014) Ancient association between cation leak channels and Mid1 proteins is conserved in fungi and animals. Front Mol Neurosci 7: 15. |
[97] |
Teng J, Goto R, Iida K, et al. (2008) Ion-channel blocker sensitivity of voltage-gated calcium-channel homologue Cch1 in Saccharomyces cerevisiae. Microbiology 154: 3775-3781. doi: 10.1099/mic.0.2008/021089-0
![]() |
[98] |
Kmetzsch L, Staats CC, Rodrigues ML, et al. (2011) Calcium signaling components in the human pathogen: Cryptococcus neoformans. Commun Integr Biol 4: 186-187. doi: 10.4161/cib.4.2.14271
![]() |
[99] |
de Castro PA, Chiaratto J, Winkelstroter LK, et al. (2014) The involvement of the Mid1/Cch1/Yvc1 calcium channels in Aspergillus fumigatus virulence. PLoS One 9: e103957. doi: 10.1371/journal.pone.0103957
![]() |
[100] |
Yang M, Brand A, Srikantha T, et al. (2011) Fig1 Facilitates Calcium Influx and Localizes to Membranes Destined To Undergo Fusion during Mating in Candida albicans. Eukaryot Cell 10: 435-444. doi: 10.1128/EC.00145-10
![]() |
[101] |
Cavinder B, Trail F (2012) Role of Fig1, a component of the low-affinity calcium uptake system, in growth and sexual development of filamentous fungi. Eukaryot Cell 11: 978-988. doi: 10.1128/EC.00007-12
![]() |
[102] |
Muller E, Mackin N, Erdman S, et al. (2003) Fig1p facilitates Ca2+ influx and cell fusion during mating of Saccharomyces cerevisiae. J Biol Chem 278: 38461-38469. doi: 10.1074/jbc.M304089200
![]() |
[103] |
Zhang S, Zheng H, Long N, et al. (2014) FigA, a putative homolog of low-affinity calcium system member Fig1 in Saccharomyces cerevisiae, is involved in growth and asexual and sexual development in Aspergillus nidulans. Eukaryot Cell 13: 295-303. doi: 10.1128/EC.00257-13
![]() |
[104] |
Van Itallie CM, Anderson JM (2006) Claudins and epithelial paracellular transport. Annu Rev Physiol 68: 403-429. doi: 10.1146/annurev.physiol.68.040104.131404
![]() |
[105] | Gunzel D, Fromm M (2012) Claudins and other tight junction proteins. Compr Physiol 2: 1819-1852. |
[106] |
Zhang N, Dudgeon D, Paliwal S, et al. (2006) Multiple signaling pathways regulate yeast cell death during the response to mating pheromones. Mol Biol Cell 17: 3409-3422. doi: 10.1091/mbc.E06-03-0177
![]() |
[107] | Brand A, Shanks S, Duncan VM, et al. (2007) Hyphal orientation of Candida albicans is regulated by a calcium-dependent mechanism. Curr Biol 17: 347-352. |
[108] |
Venkatachalam K, Montell C (2007) TRP channels. Annu Rev Biochem 76: 387-417. doi: 10.1146/annurev.biochem.75.103004.142819
![]() |
[109] |
Vrenken KS, Jalink K, van Leeuwen FN, et al. (2016) Beyond ion-conduction: Channel-dependent and -independent roles of TRP channels during development and tissue homeostasis. Biochim Biophys Acta 1863: 1436-1446. doi: 10.1016/j.bbamcr.2015.11.008
![]() |
[110] |
Palmer C, Zhou X, Lin J, et al. (2001) A TRP homolog in Saccharomyces cerevisiae forms an intracellular Ca2+-permeable channel in the yeast vacuolar membrane. Proc Natl Acad Sci U S A 98: 7801-7805. doi: 10.1073/pnas.141036198
![]() |
[111] |
Denis V, Cyert M (2002) Internal Ca2+ release in yeast is triggered by hypertonic shock and mediated by a TRP channel homologue. J Cell Biol 156: 29-34. doi: 10.1083/jcb.200111004
![]() |
[112] |
Zhou X, Batiza A, Loukin S, et al. (2003) The transient receptor potential channel on the yeast vacuole is mechanosensitive. Proc Natl Acad Sci U S A 100: 7105-7110. doi: 10.1073/pnas.1230540100
![]() |
[113] |
Chang Y, Schlenstedt G, Flockerzi V, et al. (2010) Properties of the intracellular transient receptor potential (TRP) channel in yeast, Yvc1. FEBS Lett 584: 2028-2032. doi: 10.1016/j.febslet.2009.12.035
![]() |
[114] |
Su Z, Zhou X, Loukin S, et al. (2009) Mechanical force and cytoplasmic Ca2+ activate yeast TRPY1 in parallel. J Membr Biol 227: 141-150. doi: 10.1007/s00232-009-9153-9
![]() |
[115] |
Su Z, Anishkin A, Kung C, et al. (2011) The core domain as the force sensor of the yeast mechanosensitive TRP channel. J Gen Physiol 138: 627-640. doi: 10.1085/jgp.201110693
![]() |
[116] |
Bouillet LE, Cardoso AS, Perovano E, et al. (2012) The involvement of calcium carriers and of the vacuole in the glucose-induced calcium signaling and activation of the plasma membrane H+-ATPase in Saccharomyces cerevisiae cells. Cell Calcium 51: 72-81. doi: 10.1016/j.ceca.2011.10.008
![]() |
[117] |
Yu Q, Wang F, Zhao Q, et al. (2014) A novel role of the vacuolar calcium channel Yvc1 in stress response, morphogenesis and pathogenicity of Candida albicans. Int J Med Microbiol 304: 339-350. doi: 10.1016/j.ijmm.2013.11.022
![]() |
[118] |
Prole DL, Taylor CW (2012) Identification and analysis of cation channel homologues in human pathogenic fungi. PLoS One 7: e42404. doi: 10.1371/journal.pone.0042404
![]() |
[119] |
Boratyn GM, Camacho C, Cooper PS, et al. (2013) BLAST: a more efficient report with usability improvements. Nucleic Acids Res 41: W29-33. doi: 10.1093/nar/gkt282
![]() |
[120] |
Goncalves AP, Cordeiro JM, Monteiro J, et al. (2014) Activation of a TRP-like channel and intracellular Ca2+ dynamics during phospholipase-C-mediated cell death. J Cell Sci 127: 3817-3829. doi: 10.1242/jcs.152058
![]() |
[121] |
Bonilla M, Nastase K, Cunningham K (2002) Essential role of calcineurin in response to endoplasmic reticulum stress. EMBO J 21: 2343-2353. doi: 10.1093/emboj/21.10.2343
![]() |
[122] |
Hong MP, Vu K, Bautos J, et al. (2010) Cch1 restores intracellular Ca2+ in fungal cells during endoplasmic reticulum stress. J Biol Chem 285: 10951-10958. doi: 10.1074/jbc.M109.056218
![]() |
[123] |
Okada Y, Maeno E, Shimizu T, et al. (2001) Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol 532: 3-16. doi: 10.1111/j.1469-7793.2001.0003g.x
![]() |
[124] |
Becker D, Blase C, Bereiter-Hahn J, et al. (2005) TRPV4 exhibits a functional role in cell-volume regulation. J Cell Sci 118: 2435-2440. doi: 10.1242/jcs.02372
![]() |
[125] | Numata T, Shimizu T, Okada Y (2007) TRPM7 is a stretch- and swelling-activated cation channel involved in volume regulation in human epithelial cells. Am J Physiol Cell Physiol 292: C460-467. |
[126] |
Berrier C, Besnard M, Ajouz B, et al. (1996) Multiple mechanosensitive ion channels from Escherichia coli, activated at different thresholds of applied pressure. J Membr Biol 151: 175-187. doi: 10.1007/s002329900068
![]() |
[127] |
Rigamonti M, Belotti F, Martegani E, et al. (2013) Novel role for known and unknown calcium transport involved proteins in Saccharomyces cerevisiae. Yeast 30: 157. doi: 10.1002/yea.2946
![]() |
[128] |
Protchenko O, Rodriguez-Suarez R, Androphy R, et al. (2006) A screen for genes of heme uptake identifies the FLC family required for import of FAD into the endoplasmic reticulum. J Biol Chem 281: 21445-21457. doi: 10.1074/jbc.M512812200
![]() |
[129] |
Palmer CP, Aydar E, Djamgoz MB (2005) A microbial TRP-like polycystic-kidney-disease-related ion channel gene. Biochem J 387: 211-219. doi: 10.1042/BJ20041710
![]() |
[130] |
Aydar E, Palmer CP (2009) Polycystic kidney disease channel and synaptotagmin homologues play roles in Schizosaccharomyces pombe cell wall synthesis/repair and membrane protein trafficking. J Membr Biol 229: 141-152. doi: 10.1007/s00232-009-9180-6
![]() |
[131] | Rzhetsky A, Nei M (1994) METREE: a program package for inferring and testing minimum-evolution trees. Comput Appl Biosci 10: 409-412. |
[132] |
Tamura K, Stecher G, Peterson D, et al. (2013) MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 30: 2725-2729. doi: 10.1093/molbev/mst197
![]() |
[133] |
Efron B, Halloran E, Holmes S (1996) Bootstrap confidence levels for phylogenetic trees. Proc Natl Acad Sci U S A 93: 13429-13434. doi: 10.1073/pnas.93.23.13429
![]() |
[134] | Jones DT, Taylor WR, Thornton JM (1992) The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci 8: 275-282. |
[135] | Nei M, Kumar S (2000) Molecular Evolution and Phylogenetics, Oxford University Press, New York. |
[136] | Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425. |
[137] |
Hsiang T, Baillie DL (2005) Comparison of the yeast proteome to other fungal genomes to find core fungal genes. J Mol Evol 60: 475-483. doi: 10.1007/s00239-004-0218-1
![]() |
[138] |
Bok JW, Sone T, Silverman-Gavrila LB, et al. (2001) Structure and function analysis of the calcium-related gene spray in Neurospora crassa. Fungal Genet Biol 32: 145-158. doi: 10.1006/fgbi.2000.1259
![]() |
[139] |
Stephenson KS, Gow NA, Davidson FA, et al. (2014) Regulation of vectorial supply of vesicles to the hyphal tip determines thigmotropism in Neurospora crassa. Fungal Biol 118: 287-294. doi: 10.1016/j.funbio.2013.12.007
![]() |
[140] |
Colletti GA, Kiselyov K (2011) TRPML1. Adv Exp Med Biol 704: 209-219. doi: 10.1007/978-94-007-0265-3_11
![]() |
[141] |
Puertollano R, Kiselyov K (2009) TRPMLs: in sickness and in health. Am J Physiol Renal Physiol 296: F1245-1254. doi: 10.1152/ajprenal.90522.2008
![]() |
[142] | Fares H, Greenwald I (2001) Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog. Nat Genet 28: 64-68. |
[143] |
Lima WC, Leuba F, Soldati T, et al. (2012) Mucolipin controls lysosome exocytosis in Dictyostelium. J Cell Sci 125: 2315-2322. doi: 10.1242/jcs.100362
![]() |
[144] | Dong XP, Shen D, Wang X, et al. (2010) PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca2+ release channels in the endolysosome. Nat Commun 1: 38. |
[145] |
Ma Y, Sugiura R, Koike A, et al. (2011) Transient receptor potential (TRP) and Cch1-Yam8 channels play key roles in the regulation of cytoplasmic Ca2+ in fission yeast. PLoS One 6: e22421. doi: 10.1371/journal.pone.0022421
![]() |
[146] | Bonora M, Pinton P (2014) The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death. Front Oncol 4: 302. |
[147] |
Carraro M, Giorgio V, Sileikyte J, et al. (2014) Channel formation by yeast F-ATP synthase and the role of dimerization in the mitochondrial permeability transition. J Biol Chem 289: 15980-15985. doi: 10.1074/jbc.C114.559633
![]() |
[148] |
De Stefani D, Raffaello A, Teardo E, et al. (2011) A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476: 336-340. doi: 10.1038/nature10230
![]() |
[149] |
Baughman JM, Perocchi F, Girgis HS, et al. (2011) Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476: 341-345. doi: 10.1038/nature10234
![]() |
[150] |
Marchi S, Pinton P (2014) The mitochondrial calcium uniporter complex: molecular components, structure and physiopathological implications. J Physiol 592: 829-839. doi: 10.1113/jphysiol.2013.268235
![]() |
[151] |
Uribe S, Rangel P, Pardo J (1992) Interactions of calcium with yeast mitochondria. Cell Calcium 13: 211-217. doi: 10.1016/0143-4160(92)90009-H
![]() |
[152] |
Nakayama Y, Yoshimura K, Iida H (2012) Organellar mechanosensitive channels in fission yeast regulate the hypo-osmotic shock response. Nat Commun 3: 1020. doi: 10.1038/ncomms2014
![]() |
[153] |
Nakayama Y, Hirata A, Iida H (2014) Mechanosensitive channels Msy1 and Msy2 are required for maintaining organelle integrity upon hypoosmotic shock in Schizosaccharomyces pombe. FEMS Yeast Res 14: 992-994. doi: 10.1111/1567-1364.12181
![]() |
[154] |
Gustin MC, Zhou XL, Martinac B, et al. (1988) A mechanosensitive ion channel in the yeast plasma membrane. Science 242: 762-765. doi: 10.1126/science.2460920
![]() |
[155] |
Triggle DJ (2006) L-type calcium channels. Curr Pharm Des 12: 443-457. doi: 10.2174/138161206775474503
![]() |
[156] |
Jiang L, Alber J, Wang J, et al. (2012) The Candida albicans plasma membrane protein Rch1p, a member of the vertebrate SLC10 carrier family, is a novel regulator of cytosolic Ca2+ homoeostasis. Biochem J 444: 497-502. doi: 10.1042/BJ20112166
![]() |
[157] |
Zhao Y, Yan H, Happeck R, et al. (2016) The plasma membrane protein Rch1 is a negative regulator of cytosolic calcium homeostasis and positively regulated by the calcium/calcineurin signaling pathway in budding yeast. Eur J Cell Biol 95: 164-174. doi: 10.1016/j.ejcb.2016.01.001
![]() |
[158] |
Kraus P, Heitman J (2003) Coping with stress: calmodulin and calcineurin in model and pathogenic fungi. Biochem Biophys Res Commun 311: 1151-1157. doi: 10.1016/S0006-291X(03)01528-6
![]() |
[159] |
Lewit-Bentley A, Rety S (2000) EF-hand calcium-binding proteins. Curr Opin Struct Biol 10: 637-643. doi: 10.1016/S0959-440X(00)00142-1
![]() |
[160] | Matsuura I, Ishihara K, Nakai Y, et al. (1991) A site-directed mutagenesis study of yeast calmodulin. J Biochem 109: 190-197. |
[161] |
Cyert M (2001) Genetic analysis of calmodulin and its targets in Saccharomyces cerevisiae. Annu Rev Genet 35: 647-672. doi: 10.1146/annurev.genet.35.102401.091302
![]() |
[162] |
Cruz MC, Goldstein AL, Blankenship JR, et al. (2002) Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J 21: 546-559. doi: 10.1093/emboj/21.4.546
![]() |
[163] |
Kontoyiannis DP, Lewis RE, Osherov N, et al. (2003) Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J Antimicrob Chemother 51: 313-316. doi: 10.1093/jac/dkg090
![]() |
[164] |
Steinbach WJ, Reedy JL, Cramer RA Jr, et al. (2007) Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 5: 418-430. doi: 10.1038/nrmicro1680
![]() |
[165] |
Rispail N, Soanes DM, Ant C, et al. (2009) Comparative genomics of MAP kinase and calcium-calcineurin signalling components in plant and human pathogenic fungi. Fungal Genet Biol 46: 287-298. doi: 10.1016/j.fgb.2009.01.002
![]() |
[166] |
Moser M, Lee S, Klevit R, et al. (1995) Ca2+ binding to calmodulin and its role in Schizosaccharomyces pombe as revealed by mutagenesis and NMR spectroscopy. J Biol Chem 270: 20643-20652. doi: 10.1074/jbc.270.35.20643
![]() |
[167] |
Joseph J, Means A (2002) Calcium binding is required for calmodulin function in Aspergillus nidulans. Eukaryot Cell 1: 119-125. doi: 10.1128/EC.01.1.119-125.2002
![]() |
[168] |
Davis T, Urdea M, Masiarz F, et al. (1986) Isolation of the yeast calmodulin gene: calmodulin is an essential protein. Cell 47: 423-431. doi: 10.1016/0092-8674(86)90599-4
![]() |
[169] |
Geiser J, van Tuinen D, Brockerhoff S, et al. (1991) Can calmodulin function without binding calcium? Cell 65: 949-959. doi: 10.1016/0092-8674(91)90547-C
![]() |
[170] |
Ohya Y, Botstein D (1994) Diverse essential functions revealed by complementing yeast calmodulin mutants. Science 263: 963-966. doi: 10.1126/science.8310294
![]() |
[171] |
Uttenweiler A, Schwarz H, Mayer A (2005) Microautophagic vacuole invagination requires calmodulin in a Ca2+-independent function. J Biol Chem 280: 33289-33297. doi: 10.1074/jbc.M506086200
![]() |
[172] |
Geiser JR, Sundberg HA, Chang BH, et al. (1993) The essential mitotic target of calmodulin is the 110-kilodalton component of the spindle pole body in Saccharomyces cerevisiae. Mol Cell Biol 13: 7913-7924. doi: 10.1128/MCB.13.12.7913
![]() |
[173] |
Brockerhoff S, Stevens R, Davis T (1994) The unconventional myosin, Myo2p, is a calmodulin target at sites of cell growth in Saccharomyces cerevisiae. J Cell Biol 124: 315-323. doi: 10.1083/jcb.124.3.315
![]() |
[174] |
de Carvalho MJ, Amorim Jesuino RS, Daher BS, et al. (2003) Functional and genetic characterization of calmodulin from the dimorphic and pathogenic fungus Paracoccidioides brasiliensis. Fungal Genet Biol 39: 204-210. doi: 10.1016/S1087-1845(03)00044-6
![]() |
[175] | Lee SC, Lee YH (1998) Calcium/calmodulin-dependent signaling for appressorium formation in the plant pathogenic fungus Magnaporthe grisea. Mol Cells 8: 698-704. |
[176] |
Warwar V, Oved S, Dickman MB (2000) Antisense expression of the calmodulin gene from Colletotrichum trifolii impairs prepenetration development(1). FEMS Microbiol Lett 191: 213-219. doi: 10.1111/j.1574-6968.2000.tb09342.x
![]() |
[177] |
Kraus PR, Nichols CB, Heitman J (2005) Calcium- and calcineurin-independent roles for calmodulin in Cryptococcus neoformans morphogenesis and high-temperature growth. Eukaryot Cell 4: 1079-1087. doi: 10.1128/EC.4.6.1079-1087.2005
![]() |
[178] | Ohya Y, Kawasaki H, Suzuki K, et al. (1991) Two yeast genes encoding calmodulin-dependent protein kinases. Isolation, sequencing and bacterial expressions of CMK1 and CMK2. J Biol Chem 266: 12784-12794. |
[179] |
Cyert M, Kunisawa R, Kaim D, et al. (1991) Yeast has homologs (CNA1 and CNA2 gene products) of mammalian calcineurin, a calmodulin-regulated phosphoprotein phosphatase. Proc Natl Acad Sci U S A 88: 7376-7380. doi: 10.1073/pnas.88.16.7376
![]() |
[180] |
Bodvard K, Jorhov A, Blomberg A, et al. (2013) The yeast transcription factor Crz1 is activated by light in a Ca2+/calcineurin-dependent and PKA-independent manner. PLoS One 8: e53404. doi: 10.1371/journal.pone.0053404
![]() |
[181] |
Farcasanu IC, Mitrica R, Cristache L, et al. (2013) Optical manipulation of Saccharomyces cerevisiae cells reveals that green light protection against UV irradiation is favored by low Ca2+ and requires intact UPR pathway. FEBS Lett 587: 3514-3521. doi: 10.1016/j.febslet.2013.09.008
![]() |
[182] |
Hirata D, Harada S, Namba H, et al. (1995) Adaptation to high-salt stress in Saccharomyces cerevisiae is regulated by Ca2+/calmodulin-dependent phosphoprotein phosphatase (calcineurin) and cAMP-dependent protein kinase. Mol Gen Genet 249: 257-264. doi: 10.1007/BF00290525
![]() |
[183] |
Iida H, Ohya Y, Anraku Y (1995) Calmodulin-dependent protein kinase II and calmodulin are required for induced thermotolerance in Saccharomyces cerevisiae. Curr Genet 27: 190-193. doi: 10.1007/BF00313434
![]() |
[184] |
Moser M, Geiser J, Davis T (1996) Ca2+-calmodulin promotes survival of pheromone-induced growth arrest by activation of calcineurin and Ca2+-calmodulin-dependent protein kinase. Mol Cell Biol 16: 4824-4831. doi: 10.1128/MCB.16.9.4824
![]() |
[185] |
Breuder T, Hemenway CS, Movva NR, et al. (1994) Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains. Proc Natl Acad Sci U S A 91: 5372-5376. doi: 10.1073/pnas.91.12.5372
![]() |
[186] | Hemenway CS, Dolinski K, Cardenas ME, et al. (1995) vph6 mutants of Saccharomyces cerevisiae require calcineurin for growth and are defective in vacuolar H+-ATPase assembly. Genetics 141: 833-844. |
[187] | Holyoak CD, Thompson S, Ortiz Calderon C, et al. (2000) Loss of Cmk1 Ca2+-calmodulin-dependent protein kinase in yeast results in constitutive weak organic acid resistance, associated with a post-transcriptional activation of the Pdr12 ATP-binding cassette transporter. Mol Microbiol 37: 595-605. |
[188] |
Mendoza I, Quintero FJ, Bressan RA, et al. (1996) Activated calcineurin confers high tolerance to ion stress and alters the budding pattern and cell morphology of yeast cells. J Biol Chem 271: 23061-23067. doi: 10.1074/jbc.271.38.23061
![]() |
[189] |
Cyert M (2003) Calcineurin signaling in Saccharomyces cerevisiae: how yeast go crazy in response to stress. Biochem Biophys Res Commun 311: 1143-1150. doi: 10.1016/S0006-291X(03)01552-3
![]() |
[190] |
Stathopoulos-Gerontides A, Guo J, Cyert M (1999) Yeast calcineurin regulates nuclear localization of the Crz1p transcription factor through dephosphorylation. Genes Dev 13: 798-803. doi: 10.1101/gad.13.7.798
![]() |
[191] |
Boustany L, Cyert M (2002) Calcineurin-dependent regulation of Crz1p nuclear export requires Msn5p and a conserved calcineurin docking site. Genes Dev 16: 608-619. doi: 10.1101/gad.967602
![]() |
[192] |
Yoshimoto H, Saltsman K, Gasch A, et al. (2002) Genome-wide analysis of gene expression regulated by the calcineurin/Crz1p signaling pathway in Saccharomyces cerevisiae. J Biol Chem 277: 31079-31088. doi: 10.1074/jbc.M202718200
![]() |
[193] |
Marchi V, Sorin A, Wei Y, et al. (1999) Induction of vacuolar Ca2+-ATPase and H+/Ca2+ exchange activity in yeast mutants lacking Pmr1, the Golgi Ca2+-ATPase. FEBS Lett 454: 181-186. doi: 10.1016/S0014-5793(99)00803-0
![]() |
[194] |
Cunningham K, Fink G (1996) Calcineurin inhibits VCX1-dependent H+/Ca2+ exchange and induces Ca2+ ATPases in Saccharomyces cerevisiae. Mol Cell Biol 16: 2226-2237. doi: 10.1128/MCB.16.5.2226
![]() |
[195] |
Zhao C, Jung U, Garrett-Engele P, et al. (1998) Temperature-induced expression of yeast FKS2 is under the dual control of protein kinase C and calcineurin. Mol Cell Biol 18: 1013-1022. doi: 10.1128/MCB.18.2.1013
![]() |
[196] |
Hernandez-Lopez M. J, Panadero J, Prieto JA, et al. (2006) Regulation of salt tolerance by Torulaspora delbrueckii calcineurin target Crz1p. Eukaryot Cell 5: 469-479. doi: 10.1128/EC.5.3.469-479.2006
![]() |
[197] |
Chen YL, Brand A, Morrison EL, et al. (2011) Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis. Eukaryot Cell 10: 803-819. doi: 10.1128/EC.00310-10
![]() |
[198] |
Chen YL, Yu SJ, Huang HY, et al. (2014) Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis. Eukaryot Cell 13: 844-854. doi: 10.1128/EC.00302-13
![]() |
[199] | Juvvadi PR, Kuroki Y, Arioka M, et al. (2003) Functional analysis of the calcineurin-encoding gene cnaA from Aspergillus oryzae: evidence for its putative role in stress adaptation. Arch Microbiol 179: 416-422. |
[200] |
Kothe GO, Free SJ (1998) Calcineurin subunit B is required for normal vegetative growth in Neurospora crassa. Fungal Genet Biol 23: 248-258. doi: 10.1006/fgbi.1998.1037
![]() |
[201] |
Harel A, Bercovich S, Yarden O (2006) Calcineurin is required for sclerotial development and pathogenicity of Sclerotinia sclerotiorum in an oxalic acid-independent manner. Mol Plant Microbe Interact 19: 682-693. doi: 10.1094/MPMI-19-0682
![]() |
[202] | Choi J, Kim Y, Lee Y (2009) Functional analysis of MCNA, a gene encoding a catalytic subunit of calcineurin, in the rice blast fungus Magnaporthe oryzae. J Microbiol Biotechnol 19: 11-16. |
[203] |
Cramer RA Jr, Perfect BZ, Pinchai N, et al. (2008) Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatus. Eukaryot Cell 7: 1085-1097. doi: 10.1128/EC.00086-08
![]() |
[204] |
Steinbach WJ, Cramer RA Jr, Perfect BZ et al. (2006) Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot Cell 5: 1091-1103. doi: 10.1128/EC.00139-06
![]() |
[205] |
Juvvadi PR, Fortwendel JR, Pinchai N, et al. (2008) Calcineurin localizes to the hyphal septum in Aspergillus fumigatus: implications for septum formation and conidiophore development. Eukaryot Cell 7: 1606-1610. doi: 10.1128/EC.00200-08
![]() |
[206] |
Juvvadi PR, Fortwendel JR, Rogg LE, et al. (2011) Localization and activity of the calcineurin catalytic and regulatory subunit complex at the septum is essential for hyphal elongation and proper septation in Aspergillus fumigatus. Mol Microbiol 82: 1235-1259. doi: 10.1111/j.1365-2958.2011.07886.x
![]() |
[207] |
Miyakawa T, Mizunuma M (2007) Physiological roles of calcineurin in Saccharomyces cerevisiae with special emphasis on its roles in G2/M cell-cycle regulation. Biosci Biotechnol Biochem 71: 633-645. doi: 10.1271/bbb.60495
![]() |
[208] |
Wu H, Peisley A, Graef IA, et al. (2007) NFAT signaling and the invention of vertebrates. Trends Cell Biol 17: 251-260. doi: 10.1016/j.tcb.2007.04.006
![]() |
[209] | Hirayama S, Sugiura R, Lu Y, et al. (2003) Zinc finger protein Prz1 regulates Ca2+ but not Cl- homeostasis in fission yeast. Identification of distinct branches of calcineurin signaling pathway in fission yeast. J Biol Chem 278: 18078-18084. |
[210] |
Soriani FM, Malavazi I, da Silva Ferreira ME, et al. (2008) Functional characterization of the Aspergillus fumigatus CRZ1 homologue, CrzA. Mol Microbiol 67: 1274-1291. doi: 10.1111/j.1365-2958.2008.06122.x
![]() |
[211] |
Thewes S (2014) Calcineurin-Crz1 signaling in lower eukaryotes. Eukaryot Cell 13: 694-705. doi: 10.1128/EC.00038-14
![]() |
[212] |
Zhang H, Zhao Q, Liu K, et al. (2009) MgCRZ1, a transcription factor of Magnaporthe grisea, controls growth, development and is involved in full virulence. FEMS Microbiol Lett 293: 160-169. doi: 10.1111/j.1574-6968.2009.01524.x
![]() |
[213] |
Choi J, Kim Y, Kim S, et al. (2009) MoCRZ1, a gene encoding a calcineurin-responsive transcription factor, regulates fungal growth and pathogenicity of Magnaporthe oryzae. Fungal Genet Biol 46: 243-254. doi: 10.1016/j.fgb.2008.11.010
![]() |
[214] |
Adler A, Park YD, Larsen P, et al. (2011) A novel specificity protein 1 (SP1)-like gene regulating protein kinase C-1 (Pkc1)-dependent cell wall integrity and virulence factors in Cryptococcus neoformans. J Biol Chem 286: 20977-20990. doi: 10.1074/jbc.M111.230268
![]() |
[215] |
Lev S, Desmarini D, Chayakulkeeree M, et al. (2012) The Crz1/Sp1 transcription factor of Cryptococcus neoformans is activated by calcineurin and regulates cell wall integrity. PLoS One 7: e51403. doi: 10.1371/journal.pone.0051403
![]() |
[216] | Moranova Z, Virtudazo E, Hricova K, et al. (2014) The CRZ1/SP1-like gene links survival under limited aeration, cell integrity and biofilm formation in the pathogenic yeast Cryptococcus neoformans. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 158: 212-220. |
[217] |
Santos M, de Larrinoa I (2005) Functional characterization of the Candida albicans CRZ1 gene encoding a calcineurin-regulated transcription factor. Curr Genet 48: 88-100. doi: 10.1007/s00294-005-0003-8
![]() |
[218] |
Karababa M, Valentino E, Pardini G, et al. (2006) CRZ1, a target of the calcineurin pathway in Candida albicans. Mol Microbiol 59: 1429-1451. doi: 10.1111/j.1365-2958.2005.05037.x
![]() |
[219] |
Chen YL, Konieczka JH, Springer DJ, et al. (2012) Convergent Evolution of Calcineurin Pathway Roles in Thermotolerance and Virulence in Candida glabrata. G3 (Bethesda) 2: 675-691. doi: 10.1534/g3.112.002279
![]() |
[220] |
Zhang J, Silao FG, Bigol UG, et al. (2012) Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. PLoS One 7: e44192. doi: 10.1371/journal.pone.0044192
![]() |
[221] |
Araki Y, Wu H, Kitagaki H, et al. (2009) Ethanol stress stimulates the Ca2+-mediated calcineurin/Crz1 pathway in Saccharomyces cerevisiae. J Biosci Bioeng 107: 1-6. doi: 10.1016/j.jbiosc.2008.09.005
![]() |
[222] |
Zhang T, Xu Q, Sun X, et al. (2013) The calcineurin-responsive transcription factor Crz1 is required for conidation, full virulence and DMI resistance in Penicillium digitatum. Microbiol Res 168: 211-222. doi: 10.1016/j.micres.2012.11.006
![]() |
[223] |
Calvo IA, Gabrielli N, Iglesias-Baena I, et al. (2009) Genome-wide screen of genes required for caffeine tolerance in fission yeast. PLoS One 4: e6619. doi: 10.1371/journal.pone.0006619
![]() |
[224] |
Kafadar K, Cyert M (2004) Integration of stress responses: modulation of calcineurin signaling in Saccharomyces cerevisiae by protein kinase A. Eukaryot Cell 3: 1147-1153. doi: 10.1128/EC.3.5.1147-1153.2004
![]() |
[225] |
Kafadar K, Zhu H, Snyder M, et al. (2003) Negative regulation of calcineurin signaling by Hrr25p, a yeast homolog of casein kinase I. Genes Dev 17: 2698-2708. doi: 10.1101/gad.1140603
![]() |
[226] |
Koike A, Kato T, Sugiura R, et al. (2012) Genetic screening for regulators of Prz1, a transcriptional factor acting downstream of calcineurin in fission yeast. J Biol Chem 287: 19294-19303. doi: 10.1074/jbc.M111.310615
![]() |
[227] |
Williams K, Cyert M (2001) The eukaryotic response regulator Skn7p regulates calcineurin signaling through stabilization of Crz1p. EMBO J 20: 3473-3483. doi: 10.1093/emboj/20.13.3473
![]() |
[228] |
Hernandez-Ortiz P, Espeso EA (2013) Phospho-regulation and nucleocytoplasmic trafficking of CrzA in response to calcium and alkaline-pH stress in Aspergillus nidulans. Mol Microbiol 89: 532-551. doi: 10.1111/mmi.12294
![]() |
[229] |
da Silva Ferreira ME, Heinekamp T, Hartl A, et al. (2007) Functional characterization of the Aspergillus fumigatus calcineurin. Fungal Genet Biol 44: 219-230. doi: 10.1016/j.fgb.2006.08.004
![]() |
[230] |
Ruiz A, Serrano R, Ari?o J (2008) Direct regulation of genes involved in glucose utilization by the calcium/calcineurin pathway. J Biol Chem 283: 13923-13933. doi: 10.1074/jbc.M708683200
![]() |
[231] |
Rodriguez C, Galindo LR, Siverio JM (2013) Nitrogen-dependent calcineurin activation in the yeast Hansenula polymorpha. Fungal Genet Biol 53: 34-41. doi: 10.1016/j.fgb.2013.01.007
![]() |
[232] |
Li H, Rao A, Hogan PG (2011) Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol 21: 91-103. doi: 10.1016/j.tcb.2010.09.011
![]() |
[233] |
Gorlach J, Fox DS, Cutler NS, et al. (2000) Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin in Cryptococcus neoformans. EMBO J 19: 3618-3629. doi: 10.1093/emboj/19.14.3618
![]() |
[234] |
Fuentes JJ, Pritchard MA, Estivill X (1997) Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics 44: 358-361. doi: 10.1006/geno.1997.4866
![]() |
[235] |
Hilioti Z, Gallagher DA, Low-Nam ST, et al. (2004) GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Genes Dev 18: 35-47. doi: 10.1101/gad.1159204
![]() |
[236] |
Mehta S, Li H, Hogan P, et al. (2009) Domain architecture of the regulators of calcineurin (RCANs) and identification of a divergent RCAN in yeast. Mol Cell Biol 29: 2777-2793. doi: 10.1128/MCB.01197-08
![]() |
[237] |
Kishi T, Ikeda A, Nagao R, et al. (2007) The SCFCdc4 ubiquitin ligase regulates calcineurin signaling through degradation of phosphorylated Rcn1, an inhibitor of calcineurin. Proc Natl Acad Sci U S A 104: 17418-17423. doi: 10.1073/pnas.0704951104
![]() |
[238] | Rusnak F, Mertz P (2000) Calcineurin: form and function. Physiol Rev 80: 1483-1521. |
[239] |
Connolly S, Kingsbury T (2012) Regulatory subunit myristoylation antagonizes calcineurin phosphatase activation in yeast. J Biol Chem 287: 39361-39368. doi: 10.1074/jbc.M112.366617
![]() |
[240] |
Miranda-Saavedra D, Barton GJ (2007) Classification and functional annotation of eukaryotic protein kinases. Proteins 68: 893-914. doi: 10.1002/prot.21444
![]() |
[241] | Pausch M, Kaim D, Kunisawa R, et al. (1991) Multiple Ca2+/calmodulin-dependent protein kinase genes in a unicellular eukaryote. EMBO J 10: 1511-1522. |
[242] |
Dudgeon D, Zhang N, Ositelu O, et al. (2008) Nonapoptotic death of Saccharomyces cerevisiae cells that is stimulated by Hsp90 and inhibited by calcineurin and Cmk2 in response to endoplasmic reticulum stresses. Eukaryot Cell 7: 2037-2051. doi: 10.1128/EC.00291-08
![]() |
[243] |
Rasmussen CD (2000) Cloning of a calmodulin kinase I homologue from Schizosaccharomyces pombe. J Biol Chem 275: 685-690. doi: 10.1074/jbc.275.1.685
![]() |
[244] |
Sanchez-Piris M, Posas F, Alemany V, et al. (2002) The serine/threonine kinase Cmk2 is required for oxidative stress response in fission yeast. J Biol Chem 277: 17722-17727. doi: 10.1074/jbc.M200104200
![]() |
[245] |
Ding X, Yu Q, Zhang B, et al. (2014) The type II Ca2+/calmodulin-dependent protein kinases are involved in the regulation of cell wall integrity and oxidative stress response in Candida albicans. Biochem Biophys Res Commun 446: 1073-1078. doi: 10.1016/j.bbrc.2014.03.059
![]() |
[246] |
Yang Y, Cheng P, Zhi G, et al. (2001) Identification of a calcium/calmodulin-dependent protein kinase that phosphorylates the Neurospora circadian clock protein FREQUENCY. J Biol Chem 276: 41064-41072. doi: 10.1074/jbc.M106905200
![]() |
[247] |
Dayton JS, Means AR (1996) Ca2+/calmodulin-dependent kinase is essential for both growth and nuclear division in Aspergillus nidulans. Mol Biol Cell 7: 1511-1519. doi: 10.1091/mbc.7.10.1511
![]() |
[248] |
Liu XH, Lu JP, Dong B, et al. (2010) Disruption of MoCMK1, encoding a putative calcium/calmodulin-dependent kinase, in Magnaporthe oryzae. Microbiol Res 165: 402-410. doi: 10.1016/j.micres.2009.08.007
![]() |
[249] |
Hanyu Y, Imai KK, Kawasaki Y, et al. (2009) Schizosaccharomyces pombe cell division cycle under limited glucose requires Ssp1 kinase, the putative CaMKK, and Sds23, a PP2A-related phosphatase inhibitor. Genes Cells 14: 539-554. doi: 10.1111/j.1365-2443.2009.01290.x
![]() |
[250] |
Gomez-Hierro A, Lambea E, Gimenez-Zaragoza D, et al. (2015) Ssp1 CaMKK: A Sensor of Actin Polarization That Controls Mitotic Commitment through Srk1 in Schizosaccharomyces pombe. PLoS One 10: e0143037. doi: 10.1371/journal.pone.0143037
![]() |
[251] |
Cisneros-Barroso E, Yance-Chavez T, Kito A, et al. (2014) Negative feedback regulation of calcineurin-dependent Prz1 transcription factor by the CaMKK-CaMK1 axis in fission yeast. Nucleic Acids Res 42: 9573-9587. doi: 10.1093/nar/gku684
![]() |
[252] |
Yu Q, Wang H, Cheng X, et al. (2012) Roles of Cch1 and Mid1 in morphogenesis, oxidative stress response and virulence in Candida albicans. Mycopathologia 174: 359-369. doi: 10.1007/s11046-012-9569-0
![]() |
[253] |
Eilam Y, Othman M, Halachmi D (1990) Transient increase in Ca2+ influx in Saccharomyces cerevisiae in response to glucose: effects of intracellular acidification and cAMP levels. J Gen Microbiol 136: 2537-2543. doi: 10.1099/00221287-136-12-2537
![]() |
[254] | Bouillet LE, Cardoso AS, Perovano E, et al. (2011) The involvement of calcium carriers and of the vacuole in the glucose-induced calcium signaling and activation of the plasma membrane H+-ATPase in Saccharomyces cerevisiae cells. Cell Calcium 51: 72-81. |
[255] |
Tr��pia M, Cardoso A, Tisi R, et al. (2006) Calcium signaling and sugar-induced activation of plasma membrane H+-ATPase in Saccharomyces cerevisiae cells. Biochem Biophys Res Commun 343: 1234-1243. doi: 10.1016/j.bbrc.2006.03.078
![]() |
[256] |
Zhang Y, Rao R (2008) A spoke in the wheel: calcium spikes disrupt yeast cell cycle. Cell Cycle 7: 870-873. doi: 10.4161/cc.7.7.5616
![]() |
[257] |
Burgoyne R, Clague M (2003) Calcium and calmodulin in membrane fusion. Biochim Biophys Acta 1641: 137-143. doi: 10.1016/S0167-4889(03)00089-2
![]() |
[258] |
Garrett-Engele P, Moilanen B, Cyert M (1995) Calcineurin, the Ca2+/calmodulin-dependent protein phosphatase, is essential in yeast mutants with cell integrity defects and in mutants that lack a functional vacuolar H+-ATPase. Mol Cell Biol 15: 4103-4114. doi: 10.1128/MCB.15.8.4103
![]() |
[259] |
Deka R, Kumar R, Tamuli R (2011) Neurospora crassa homologue of Neuronal Calcium Sensor-1 has a role in growth, calcium stress tolerance, and ultraviolet survival. Genetica 139: 885-894. doi: 10.1007/s10709-011-9592-y
![]() |
[260] |
Deka R, Tamuli R (2013) Neurospora crassa ncs-1, mid-1 and nca-2 double-mutant phenotypes suggest diverse interaction among three Ca2+-regulating gene products. J Genet 92: 559-563. doi: 10.1007/s12041-013-0270-y
![]() |
[261] |
Tamuli R, Kumar R, Deka R (2011) Cellular roles of neuronal calcium sensor-1 and calcium/calmodulin-dependent kinases in fungi. J Basic Microbiol 51: 120-128. doi: 10.1002/jobm.201000184
![]() |
[262] |
Barman A, Tamuli R (2015) Multiple cellular roles of Neurospora crassa plc-1, splA2, and cpe-1 in regulation of cytosolic free calcium, carotenoid accumulation, stress responses, and acquisition of thermotolerance. J Microbiol 53: 226-235. doi: 10.1007/s12275-015-4465-1
![]() |
[263] |
Tamuli R, Deka R, Borkovich KA (2016) Calcineurin Subunits A and B Interact to Regulate Growth and Asexual and Sexual Development in Neurospora crassa. PLoS One 11: e0151867. doi: 10.1371/journal.pone.0151867
![]() |
[264] | Davenport K, Sohaskey M, Kamada Y, et al. (1995) A second osmosensing signal transduction pathway in yeast. Hypotonic shock activates the PKC1 protein kinase-regulated cell integrity pathway. J Biol Chem 270: 30157-30161. |
[265] |
Mizunuma M, Hirata D, Miyahara K, et al. (1998) Role of calcineurin and Mpk1 in regulating the onset of mitosis in budding yeast. Nature 392: 303-306. doi: 10.1038/32695
![]() |
[266] |
Levin DE (2005) Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 69: 262-291. doi: 10.1128/MMBR.69.2.262-291.2005
![]() |
[267] | Nakamura T, Ohmoto T, Hirata D, et al. (1996) Genetic evidence for the functional redundancy of the calcineurin- and Mpk1-mediated pathways in the regulation of cellular events important for growth in Saccharomyces cerevisiae. Mol Gen Genet 251: 211-219. |
[268] |
Mazur P, Morin N, Baginsky W, et al. (1995) Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase. Mol Cell Biol 15: 5671-5681. doi: 10.1128/MCB.15.10.5671
![]() |
[269] |
Wang X, Sheff MA, Simpson DM, et al. (2011) Ste11p MEKK signals through HOG, mating, calcineurin and PKC pathways to regulate the FKS2 gene. BMC Mol Biol 12: 51. doi: 10.1186/1471-2199-12-51
![]() |
[270] |
Serrano R, Ruiz A, Bernal D, et al. (2002) The transcriptional response to alkaline pH in Saccharomyces cerevisiae: evidence for calcium-mediated signalling. Mol Microbiol 46: 1319-1333. doi: 10.1046/j.1365-2958.2002.03246.x
![]() |
[271] |
Lavina WA, Hermansyah, Sugiyama M, et al. (2013) Functionally redundant protein phosphatase genes PTP2 and MSG5 co-regulate the calcium signaling pathway in Saccharomyces cerevisiae upon exposure to high extracellular calcium concentration. J Biosci Bioeng 115: 138-146. doi: 10.1016/j.jbiosc.2012.08.022
![]() |
[272] |
Lagorce A, Hauser NC, Labourdette D, et al. (2003) Genome-wide analysis of the response to cell wall mutations in the yeast Saccharomyces cerevisiae. J Biol Chem 278: 20345-20357. doi: 10.1074/jbc.M211604200
![]() |
[273] |
Colabardini AC, Ries LN, Brown NA, et al. (2014) Protein kinase C overexpression suppresses calcineurin-associated defects in Aspergillus nidulans and is involved in mitochondrial function. PLoS One 9: e104792. doi: 10.1371/journal.pone.0104792
![]() |
[274] |
Teepe AG, Loprete DM, He Z, et al. (2007) The protein kinase C orthologue PkcA plays a role in cell wall integrity and polarized growth in Aspergillus nidulans. Fungal Genet Biol 44: 554-562. doi: 10.1016/j.fgb.2006.10.001
![]() |
[275] |
Herrmann M, Sprote P, Brakhage AA (2006) Protein kinase C (PkcA) of Aspergillus nidulans is involved in penicillin production. Appl Environ Microbiol 72: 2957-2970. doi: 10.1128/AEM.72.4.2957-2970.2006
![]() |
[276] |
Ichinomiya M, Uchida H, Koshi Y, et al. (2007) A protein kinase C-encoding gene, pkcA, is essential to the viability of the filamentous fungus Aspergillus nidulans. Biosci Biotechnol Biochem 71: 2787-2799. doi: 10.1271/bbb.70409
![]() |
[277] |
Ronen R, Sharon H, Levdansky E, et al. (2007) The Aspergillus nidulans pkcA gene is involved in polarized growth, morphogenesis and maintenance of cell wall integrity. Curr Genet 51: 321-329. doi: 10.1007/s00294-007-0129-y
![]() |
[278] |
Colabardini AC, De Castro PA, De Gouvea PF, et al. (2010) Involvement of the Aspergillus nidulans protein kinase C with farnesol tolerance is related to the unfolded protein response. Mol Microbiol 78: 1259-1279. doi: 10.1111/j.1365-2958.2010.07403.x
![]() |
[279] |
Katayama T, Uchida H, Ohta A, et al. (2012) Involvement of protein kinase C in the suppression of apoptosis and in polarity establishment in Aspergillus nidulans under conditions of heat stress. PLoS One 7: e50503. doi: 10.1371/journal.pone.0050503
![]() |
[280] |
Schumacher J, Viaud M, Simon A, et al. (2008) The Galpha subunit BCG1, the phospholipase C (BcPLC1) and the calcineurin phosphatase co-ordinately regulate gene expression in the grey mould fungus Botrytis cinerea. Mol Microbiol 67: 1027-1050. doi: 10.1111/j.1365-2958.2008.06105.x
![]() |
[281] |
Lev S, Desmarini D, Li C, et al. (2013) Phospholipase C of Cryptococcus neoformans regulates homeostasis and virulence by providing inositol trisphosphate as a substrate for Arg1 kinase. Infect Immun 81: 1245-1255. doi: 10.1128/IAI.01421-12
![]() |
[282] |
Galagan JE, Calvo SE, Borkovich KA, et al. (2003) The genome sequence of the filamentous fungus Neurospora crassa. Nature 422: 859-868. doi: 10.1038/nature01554
![]() |
[283] |
Borkovich KA, Alex LA, Yarden O, et al. (2004) Lessons from the genome sequence of Neurospora crassa: tracing the path from genomic blueprint to multicellular organism. Microbiol Mol Biol Rev 68: 1-108. doi: 10.1128/MMBR.68.1.1-108.2004
![]() |
[284] |
Silverman-Gavrila LB, Lew RR (2002) An IP3-activated Ca2+ channel regulates fungal tip growth. J Cell Sci 115: 5013-5025. doi: 10.1242/jcs.00180
![]() |
[285] |
Silverman-Gavrila LB, Lew RR (2003) Calcium gradient dependence of Neurospora crassa hyphal growth. Microbiology 149: 2475-2485. doi: 10.1099/mic.0.26302-0
![]() |
[286] |
Silverman-Gavrila LB, Lew RR (2001) Regulation of the tip-high [Ca2+] gradient in growing hyphae of the fungus Neurospora crassa. Eur J Cell Biol 80: 379-390. doi: 10.1078/0171-9335-00175
![]() |
[287] |
Rho HS, Jeon J, Lee YH (2009) Phospholipase C-mediated calcium signalling is required for fungal development and pathogenicity in Magnaporthe oryzae. Mol Plant Pathol 10: 337-346. doi: 10.1111/j.1364-3703.2009.00536.x
![]() |
[288] |
Choi J, Kim KS, Rho HS, et al. (2011) Differential roles of the phospholipase C genes in fungal development and pathogenicity of Magnaporthe oryzae. Fungal Genet Biol 48: 445-455. doi: 10.1016/j.fgb.2011.01.001
![]() |
[289] |
Flick JS, Thorner J (1993) Genetic and biochemical characterization of a phosphatidylinositol-specific phospholipase C in Saccharomyces cerevisiae. Mol Cell Biol 13: 5861-5876. doi: 10.1128/MCB.13.9.5861
![]() |
[290] |
Payne W, Fitzgerald-Hayes M (1993) A mutation in PLC1, a candidate phosphoinositide-specific phospholipase C gene from Saccharomyces cerevisiae, causes aberrant mitotic chromosome segregation. Mol Cell Biol 13: 4351-4364. doi: 10.1128/MCB.13.7.4351
![]() |
[291] | DeLillo N, Romero C, Lin H, et al. (2003) Genetic evidence for a role of phospholipase C at the budding yeast kinetochore. Mol Genet Genomics 269: 261-270. |
[292] |
Jun Y, Fratti R, Wickner W (2004) Diacylglycerol and its formation by phospholipase C regulate Rab- and SNARE-dependent yeast vacuole fusion. J Biol Chem 279: 53186-53195. doi: 10.1074/jbc.M411363200
![]() |
[293] |
Banfic H, Bedalov A, York JD, et al. (2013) Inositol pyrophosphates modulate S phase progression after pheromone-induced arrest in Saccharomyces cerevisiae. J Biol Chem 288: 1717-1725. doi: 10.1074/jbc.M112.412288
![]() |
[294] |
Coccetti P, Tisi R, Martegani E, et al. (1998) The PLC1 encoded phospholipase C in the yeast Saccharomyces cerevisiae is essential for glucose-induced phosphatidylinositol turnover and activation of plasma membrane H+-ATPase. Biochim Biophys Acta 1405: 147-154. doi: 10.1016/S0167-4889(98)00099-8
![]() |
[295] |
Nakajima-Shimada J, Iida H, Tsuji F, et al. (1991) Monitoring of intracellular calcium in Saccharomyces cerevisiae with an apoaequorin cDNA expression system. Proc Natl Acad Sci U S A 88: 6878-6882. doi: 10.1073/pnas.88.15.6878
![]() |
[296] |
Tisi R, Belotti F, Wera S, et al. (2004) Evidence for inositol triphosphate as a second messenger for glucose-induced calcium signalling in budding yeast. Curr Genet 45: 83-89. doi: 10.1007/s00294-003-0465-5
![]() |
[297] |
Cavero S, Traba J, Del Arco A, et al. (2005) The calcium-dependent ATP-Mg/Pi mitochondrial carrier is a target of glucose-induced calcium signalling in Saccharomyces cerevisiae. Biochem J. 392: 537-544. doi: 10.1042/BJ20050806
![]() |
[298] |
Bergsma J, Kasri N, Donaton M, et al. (2001) PtdIns(4,5)P(2) and phospholipase C-independent Ins(1,4,5)P(3) signals induced by a nitrogen source in nitrogen-starved yeast cells. Biochem J 359: 517-523. doi: 10.1042/bj3590517
![]() |
[299] |
Guillas I, Vernay A, Vitagliano JJ, et al. (2013) Phosphatidylinositol 4,5-bisphosphate is required for invasive growth in Saccharomyces cerevisiae. J Cell Sci 126: 3602-3614. doi: 10.1242/jcs.122606
![]() |
[300] | Rebecchi MJ, Pentyala SN (2000) Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 80: 1291-1335. |
[301] | Guiney EL, Goldman AR, Elias JE, et al. (2014) Calcineurin regulates the yeast synaptojanin Inp53/Sjl3 during membrane stress. Mol Biol Cell 26: 769-785. |
[302] |
Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8: 519-529. doi: 10.1038/nrm2199
![]() |
[303] |
Mori K (2009) Signalling pathways in the unfolded protein response: development from yeast to mammals. J Biochem 146: 743-750. doi: 10.1093/jb/mvp166
![]() |
[304] |
Chen Y, Feldman DE, Deng C, et al. (2005) Identification of mitogen-activated protein kinase signaling pathways that confer resistance to endoplasmic reticulum stress in Saccharomyces cerevisiae. Mol Cancer Res 3: 669-677. doi: 10.1158/1541-7786.MCR-05-0181
![]() |
[305] |
Nikawa J, Yamashita S (1992) IRE1 encodes a putative protein kinase containing a membrane-spanning domain and is required for inositol phototrophy in Saccharomyces cerevisiae. Mol Microbiol 6: 1441-1446. doi: 10.1111/j.1365-2958.1992.tb00864.x
![]() |
[306] |
Nikawa J, Akiyoshi M, Hirata S, et al. (1996) Saccharomyces cerevisiae IRE2/HAC1 is involved in IRE1-mediated KAR2 expression. Nucleic Acids Res 24: 4222-4226. doi: 10.1093/nar/24.21.4222
![]() |
[307] |
Kim H, Kim A, Cunningham KW (2012) Vacuolar H+-ATPase (V-ATPase) promotes vacuolar membrane permeabilization and nonapoptotic death in stressed yeast. J Biol Chem 287: 19029-19039. doi: 10.1074/jbc.M112.363390
![]() |
[308] |
Kajiwara K, Muneoka T, Watanabe Y, et al. (2012) Perturbation of sphingolipid metabolism induces endoplasmic reticulum stress-mediated mitochondrial apoptosis in budding yeast. Mol Microbiol 86: 1246-1261. doi: 10.1111/mmi.12056
![]() |
[309] |
van Meer G, Voelker DR, Feigenson GW (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9: 112-124. doi: 10.1038/nrm2330
![]() |
[310] |
Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139-150. doi: 10.1038/nrm2329
![]() |
[311] |
Jayaraman T, Marks AR (2000) Calcineurin is downstream of the inositol 1,4,5-trisphosphate receptor in the apoptotic and cell growth pathways. J Biol Chem 275: 6417-6420. doi: 10.1074/jbc.275.9.6417
![]() |
[312] |
Perrone GG, Tan SX, Dawes IW (2008) Reactive oxygen species and yeast apoptosis. Biochim Biophys Acta 1783: 1354-1368. doi: 10.1016/j.bbamcr.2008.01.023
![]() |
[313] |
Schroder M (2008) Engineering eukaryotic protein factories. Biotechnol Lett 30: 187-196. doi: 10.1007/s10529-007-9524-1
![]() |
[314] |
Giorgi C, De Stefani D, Bononi A, et al. (2009) Structural and functional link between the mitochondrial network and the endoplasmic reticulum. Int J Biochem Cell Biol 41: 1817-1827. doi: 10.1016/j.biocel.2009.04.010
![]() |
[315] |
Cebulski J, Malouin J, Pinches N, et al. (2011) Yeast Bax inhibitor, Bxi1p, is an ER-localized protein that links the unfolded protein response and programmed cell death in Saccharomyces cerevisiae. PLoS One 6: e20882. doi: 10.1371/journal.pone.0020882
![]() |
[316] |
Alby K, Schaefer D, Sherwood RK, et al. (2010) Identification of a cell death pathway in Candida albicans during the response to pheromone. Eukaryot Cell 9: 1690-1701. doi: 10.1128/EC.00155-10
![]() |
[317] |
Lu H, Zhu Z, Dong L, et al. (2011) Lack of trehalose accelerates H2O2-induced Candida albicans apoptosis through regulating Ca2+ signaling pathway and caspase activity. PLoS One 6: e15808. doi: 10.1371/journal.pone.0015808
![]() |
[318] |
Hwang JH, Choi H, Kim AR, et al. (2014) Hibicuslide C-induced cell death in Candida albicans involves apoptosis mechanism. J Appl Microbiol 117: 1400-1411. doi: 10.1111/jam.12633
![]() |
[319] |
Gupta S, Ton V, Beaudry V, et al. (2003) Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis. J Biol Chem 278: 28831-28839. doi: 10.1074/jbc.M303300200
![]() |
[320] |
Pozniakovsky AI, Knorre DA, Markova OV, et al. (2005) Role of mitochondria in the pheromone- and amiodarone-induced programmed death of yeast. J Cell Biol 168: 257-269. doi: 10.1083/jcb.200408145
![]() |
[321] | Zheng K, Pan J, Ye L, et al. (2007) Programmed cell death-involved aluminum toxicity in yeast alleviated by antiapoptotic members with decreased calcium signals. Plant Physiol 143: 38-49. |
[322] |
Pereira C, Silva RD, Saraiva L, et al. (2008) Mitochondria-dependent apoptosis in yeast. Biochim Biophys Acta 1783: 1286-1302. doi: 10.1016/j.bbamcr.2008.03.010
![]() |
[323] | Lauff DB, Santa-Maria GE (2010) Potassium deprivation is sufficient to induce a cell death program in Saccharomyces cerevisiae. FEMS Yeast Res 10: 497-507. |
[324] |
Gunter TE, Sheu SS (2009) Characteristics and possible functions of mitochondrial Ca2+ transport mechanisms. Biochim Biophys Acta 1787: 1291-1308. doi: 10.1016/j.bbabio.2008.12.011
![]() |
[325] |
Chinopoulos C, Adam-Vizi V (2010) Mitochondrial Ca2+ sequestration and precipitation revisited. FEBS J 277: 3637-3651. doi: 10.1111/j.1742-4658.2010.07755.x
![]() |
[326] |
Williams GS, Boyman L, Chikando AC, et al. (2013) Mitochondrial calcium uptake. Proc Natl Acad Sci U S A 110: 10479-10486. doi: 10.1073/pnas.1300410110
![]() |
[327] |
Virag A, Harris SD (2006) The Spitzenkorper: a molecular perspective. Mycol Res 110: 4-13. doi: 10.1016/j.mycres.2005.09.005
![]() |
[328] |
Muend S, Rao R (2008) Fungicidal activity of amiodarone is tightly coupled to calcium influx. FEMS Yeast Res 8: 425-431. doi: 10.1111/j.1567-1364.2008.00354.x
![]() |
[329] |
Roberts SK, McAinsh M, Widdicks L (2012) Cch1p mediates Ca2+ influx to protect Saccharomyces cerevisiae against eugenol toxicity. PLoS One 7: e43989. doi: 10.1371/journal.pone.0043989
![]() |
[330] |
Imura A, Tsuji Y, Murata M, et al. (2007) ��-Klotho as a Regulator of Calcium Homeostasis. Science 316: 1615-1618. doi: 10.1126/science.1135901
![]() |
[331] | Yokoyama H, Mizunuma M, Okamoto M, et al. (2006) Involvement of calcineurin-dependent degradation of Yap1p in Ca2+-induced G2 cell-cycle regulation in Saccharomyces cerevisiae. EMBO Rep 7: 519-524. |
[332] |
Tsubakiyama R, Mizunuma M, Gengyo A, et al. (2011) Implication of Ca2+ in the regulation of replicative life span of budding yeast. J Biol Chem 286: 28681-28687. doi: 10.1074/jbc.M111.231415
![]() |
[333] |
Maeta K, Izawa S, Inoue Y (2005) Methylglyoxal, a metabolite derived from glycolysis, functions as a signal initiator of the high osmolarity glycerol-mitogen-activated protein kinase cascade and calcineurin/Crz1-mediated pathway in Saccharomyces cerevisiae. J Biol Chem 280: 253-260. doi: 10.1074/jbc.M408061200
![]() |
[334] | Shitamukai A, Hirata D, Sonobe S, et al. (2004) Evidence for antagonistic regulation of cell growth by the calcineurin and high osmolarity glycerol pathways in Saccharomyces cerevisiae. J Biol Chem 279: 3651-3661. |
[335] |
Kullas AL, Martin SJ, Davis D (2007) Adaptation to environmental pH: integrating the Rim101 and calcineurin signal transduction pathways. Mol Microbiol 66: 858-871. doi: 10.1111/j.1365-2958.2007.05929.x
![]() |
[336] |
Lengeler KB, Davidson RC, D'Souza C, et al. (2000) Signal transduction cascades regulating fungal development and virulence. Microbiol Mol Biol Rev 64: 746-785. doi: 10.1128/MMBR.64.4.746-785.2000
![]() |
[337] |
Marchetti O, Entenza JM, Sanglard D, et al. (2000) Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans. Antimicrob Agents Chemother 44: 2932-2938. doi: 10.1128/AAC.44.11.2932-2938.2000
![]() |
[338] |
Marchetti O, Moreillon P, Glauser MP, et al. (2000) Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother 44: 2373-2381. doi: 10.1128/AAC.44.9.2373-2381.2000
![]() |
[339] |
Reedy JL, Filler SG, Heitman J (2010) Elucidating the Candida albicans calcineurin signaling cascade controlling stress response and virulence. Fungal Genet Biol 47: 107-116. doi: 10.1016/j.fgb.2009.09.002
![]() |
[340] |
Miyazaki T, Yamauchi S, Inamine T, et al. (2010) Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata. Antimicrob Agents Chemother 54: 1639-1643. doi: 10.1128/AAC.01364-09
![]() |
[341] |
Seider K, Gerwien F, Kasper L, et al. (2014) Immune evasion, stress resistance, and efficient nutrient acquisition are crucial for intracellular survival of Candida glabrata within macrophages. Eukaryot Cell 13: 170-183. doi: 10.1128/EC.00262-13
![]() |
[342] |
Odom A, Muir S, Lim E, et al. (1997) Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J 16: 2576-2589. doi: 10.1093/emboj/16.10.2576
![]() |
[343] |
Liu S, Hou Y, Liu W, et al. (2015) Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targets. Eukaryot Cell 14: 324-334. doi: 10.1128/EC.00271-14
![]() |
[344] | Blankenship JR, Steinbach WJ, Perfect JR, et al. (2003) Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugs. Curr Opin Investig Drugs 4: 192-199. |
[345] |
Cruz MC, Del Poeta M, Wang P, et al. (2000) Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin. Antimicrob Agents Chemother 44: 143-149. doi: 10.1128/AAC.44.1.143-149.2000
![]() |
[346] |
Cruz MC, Goldstein AL, Blankenship J, et al. (2001) Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrob Agents Chemother 45: 3162-3170. doi: 10.1128/AAC.45.11.3162-3170.2001
![]() |
[347] |
Rodr��guez A, Roy J, Mart��nez-Mart��nez S, et al. (2009) A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants. Mol Cell 33: 616-626. doi: 10.1016/j.molcel.2009.01.030
![]() |
[348] |
Edlind T, Smith L, Henry K, et al. (2002) Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling. Mol Microbiol 46: 257-268. doi: 10.1046/j.1365-2958.2002.03165.x
![]() |
[349] |
Maesaki S, Marichal P, Hossain MA, et al. (1998) Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albicans strains. J Antimicrob Chemother 42: 747-753. doi: 10.1093/jac/42.6.747
![]() |
[350] |
Steinbach WJ, Schell WA, Blankenship JR, et al. (2004) In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother 48: 1664-1669. doi: 10.1128/AAC.48.5.1664-1669.2004
![]() |
[351] |
Schumacher J, de Larrinoa IF, Tudzynski B (2008) Calcineurin-responsive zinc finger transcription factor CRZ1 of Botrytis cinerea is required for growth, development, and full virulence on bean plants. Eukaryot Cell 7: 584-601. doi: 10.1128/EC.00426-07
![]() |
[352] |
Onyewu C, Wormley FL Jr, Perfect JR, et al. (2004) The calcineurin target, Crz1, functions in azole tolerance but is not required for virulence of Candida albicans. Infect Immun 72: 7330-7333. doi: 10.1128/IAI.72.12.7330-7333.2004
![]() |
[353] | Nakamura T, Takahashi H (2006) Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia. J Infect Chemother 12: 132-138. |
[354] | Rogers TR (2002) Antifungal drug resistance: does it matter? Int J Infect Dis 6: S47-53. |
[355] | Berman J, Sudbery PE (2002) Candida albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet 3: 918-930. |
[356] |
Lopez-Ribot JL (2005) Candida albicans biofilms: more than filamentation. Curr Biol 15: R453-455. doi: 10.1016/j.cub.2005.06.020
![]() |
[357] | Lo HJ, K?hler JR, DiDomenico B, et al. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949. |
[358] |
Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11: 30-36. doi: 10.1016/S0966-842X(02)00002-1
![]() |
[359] | Hawser SP, Douglas LJ (1994) Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62: 915-921. |
[360] |
Liu H (2001) Transcriptional control of dimorphism in Candida albicans. Curr Opin Microbiol 4: 728-735. doi: 10.1016/S1369-5274(01)00275-2
![]() |
[361] |
Nobile CJ, Fox EP, Nett JE, et al. (2012) A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148: 126-138. doi: 10.1016/j.cell.2011.10.048
![]() |
[362] |
Brown AJ, Gow NA (1999) Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol 7: 333-338. doi: 10.1016/S0966-842X(99)01556-5
![]() |
[363] |
Sabie FT, Gadd GM (1989) Involvement of a Ca2+-calmodulin interaction in the yeast-mycelial (Y-M) transition of Candida albicans. Mycopathologia 108: 47-54. doi: 10.1007/BF00436783
![]() |
[364] |
Blankenship JR, Wormley FL, Boyce MK, et al. (2003) Calcineurin is essential for Candida albicans survival in serum and virulence. Eukaryot Cell 2: 422-430. doi: 10.1128/EC.2.3.422-430.2003
![]() |
[365] |
Blankenship JR, Heitman J (2005) Calcineurin is required for Candida albicans to survive calcium stress in serum. Infect Immun 73: 5767-5774. doi: 10.1128/IAI.73.9.5767-5774.2005
![]() |
[366] |
Sanglard D, Ischer F, Marchetti O, et al. (2003) Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol 48: 959-976. doi: 10.1046/j.1365-2958.2003.03495.x
![]() |
[367] |
Onyewu C, Blankenship JR, Del Poeta M, et al. (2003) Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob Agents Chemother 47: 956-964. doi: 10.1128/AAC.47.3.956-964.2003
![]() |
[368] |
Riscili BP, Wood KL (2009) Noninvasive pulmonary Aspergillus infections. Clin Chest Med 30: 315-335, vii. doi: 10.1016/j.ccm.2009.02.008
![]() |
[369] |
Lelievre L, Groh M, Angebault C, et al. (2013) Azole resistant Aspergillus fumigatus: an emerging problem. Med Mal Infect 43: 139-145. doi: 10.1016/j.medmal.2013.02.010
![]() |
[370] |
Denning DW, Perlin DS (2011) Azole resistance in Aspergillus: a growing public health menace. Future Microbiol 6: 1229-1232. doi: 10.2217/fmb.11.118
![]() |
[371] |
Todd RB, Davis MA, Hynes MJ (2007) Genetic manipulation of Aspergillus nidulans: heterokaryons and diploids for dominance, complementation and haploidization analyses. Nat Protoc 2: 822-830. doi: 10.1038/nprot.2007.113
![]() |
[372] |
Todd RB, Davis MA, Hynes MJ (2007) Genetic manipulation of Aspergillus nidulans: meiotic progeny for genetic analysis and strain construction. Nat Protoc 2: 811-821. doi: 10.1038/nprot.2007.112
![]() |
[373] |
Srikanta D, Santiago-Tirado FH, Doering TL (2014) Cryptococcus neoformans: historical curiosity to modern pathogen. Yeast 31: 47-60. doi: 10.1002/yea.2997
![]() |
[374] |
Perfect JR, Casadevall A (2002) Cryptococcosis. Infect Dis Clin North Am 16: 837-874. doi: 10.1016/S0891-5520(02)00036-3
![]() |
[375] |
Steenbergen JN, Casadevall A (2003) The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect 5: 667-675. doi: 10.1016/S1286-4579(03)00092-3
![]() |
[376] |
Brown SM, Campbell LT, Lodge JK (2007) Cryptococcus neoformans, a fungus under stress. Curr Opin Microbiol 10: 320-325. doi: 10.1016/j.mib.2007.05.014
![]() |
[377] |
Bahn YS, Jung KW (2013) Stress signaling pathways for the pathogenicity of Cryptococcus. Eukaryot Cell 12: 1564-1577. doi: 10.1128/EC.00218-13
![]() |
[378] |
Fox DS, Cruz MC, Sia RA, et al. (2001) Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans. Mol Microbiol 39: 835-849. doi: 10.1046/j.1365-2958.2001.02295.x
![]() |
[379] |
Kozubowski L, Aboobakar EF, Cardenas ME, et al. (2011) Calcineurin colocalizes with P-bodies and stress granules during thermal stress in Cryptococcus neoformans. Eukaryot Cell 10: 1396-1402. doi: 10.1128/EC.05087-11
![]() |
[380] |
Cruz MC, Fox DS, Heitman J (2001) Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans. EMBO J 20: 1020-1032. doi: 10.1093/emboj/20.5.1020
![]() |
[381] |
Fox DS, Heitman J (2002) Good fungi gone bad: the corruption of calcineurin. Bioessays 24: 894-903. doi: 10.1002/bies.10157
![]() |
[382] |
Kraus PR, Fox DS, Cox GM, et al. (2003) The Cryptococcus neoformans MAP kinase Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function. Mol Microbiol 48: 1377-1387. doi: 10.1046/j.1365-2958.2003.03508.x
![]() |
[383] | Thompson JR, Douglas CM, Li W, et al. (1999) A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function. J Bacteriol 181: 444-453. |
[384] |
Juvvadi PR, Gehrke C, Fortwendel JR, et al. (2013) Phosphorylation of Calcineurin at a novel serine-proline rich region orchestrates hyphal growth and virulence in Aspergillus fumigatus. PLoS Pathog 9: e1003564. doi: 10.1371/journal.ppat.1003564
![]() |
[385] |
Bates S, MacCallum DM, Bertram G, et al. (2005) Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence. J Biol Chem 280: 23408-23415. doi: 10.1074/jbc.M502162200
![]() |
[386] |
LaFayette SL, Collins C, Zaas AK, et al. (2010) PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. PLoS Pathog 6: e1001069. doi: 10.1371/journal.ppat.1001069
![]() |
[387] |
Yu Q, Ding X, Zhang B, et al. (2014) Inhibitory effect of verapamil on Candida albicans hyphal development, adhesion and gastrointestinal colonization. FEMS Yeast Res 14: 633-641. doi: 10.1111/1567-1364.12150
![]() |
[388] |
Ramage G, Wickes BL, Lopez-Ribot JL (2007) Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia 164: 301-306. doi: 10.1007/s11046-007-9068-x
![]() |
[389] |
Raad II, Hachem RY, Hanna HA, et al. (2008) Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents 32: 515-518. doi: 10.1016/j.ijantimicag.2008.06.020
![]() |
[390] |
Yu Q, Ding X, Xu N, et al. (2013) In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms. Int J Antimicrob Agents 41: 179-182. doi: 10.1016/j.ijantimicag.2012.10.009
![]() |
[391] |
Kmetzsch L, Staats CC, Cupertino JB, et al. (2013) The calcium transporter Pmc1 provides Ca2+ tolerance and influences the progression of murine cryptococcal infection. FEBS J 280: 4853-4864. doi: 10.1111/febs.12458
![]() |
1. | Renzhi Lv, Yifei Dong, Zhijie Bao, Simin Zhang, Songyi Lin, Na Sun, Advances in the activity evaluation and cellular regulation pathways of food-derived antioxidant peptides, 2022, 122, 09242244, 171, 10.1016/j.tifs.2022.02.026 | |
2. | Yanli Liu, Xia Gong, Juan Wang, Yongxiang Wang, Yong Zhang, Tao Li, Juan Yan, Min Zhou, Benzhong Zhang, Investigation of nickel sulfate‐induced cytotoxicity and underlying toxicological mechanisms in human umbilical vein endothelial cells through oxidative stress, inflammation, apoptosis, and MAPK signaling pathways , 2022, 37, 1520-4081, 2058, 10.1002/tox.23550 | |
3. | Atif Ali, Kiran Kareem Bukhsh, Muhammad Mohsin Raza, Muhammad Talha Afraz, Tazeddinova Diana, Muhammad Waseem, Muhammad Faisal Manzoor, Gholamreza Abdi, Exploring the structure–activity relationships and molecular mechanisms of food-derived antioxidative peptides in mitigating oxidative stress: A comprehensive review, 2025, 127, 17564646, 106751, 10.1016/j.jff.2025.106751 |
MAPK signalling | Study models | Consequences/summary | |||
In-vitro | In-vivo | Ex-vivo | Humans | ||
p38 MAPK isoforms | WT-mice | Cardiac dysfunction were restored by TG DN p38α MAPK | |||
Human monocytes Eucaryotic cells | Dog Monkeys | Humans | Increased inflammatory factors, cytokines and p38β MAPK were reversed by p38 MAPK inhibitor | ||
Cardio-myocytes | p38 MAPK inhibition attenuates cardiomyocyte growth in response to hypertrophic stimuli. over-expression of p38α MAPK reduced anti-apoptotic protein Bcl-xl expression, and p38 inhibition reduced stress-induced apoptosis |
||||
SD-rats | BPS treatment inhibits p38 MAPK, TNF-α, HIF-1α, MMP-9, BNP, ANP, myocardial cell apoptosis & delays the progression of DMHF in condition heart | ||||
SFMCs HFLSs PBMCs |
MK2 inhibitors decreases the expression of immune mediated inflammatory factors | ||||
Humans | p38 MAPK was activated in human heart samples of idiopathic dilated cardiomyopathy and ischemic heart disease. Suppressing it improves LV function, and myocardial infarction. |
Notes: WT: wild type; SD: sprague dawley; SFMCs: synovial fluid mononuclear cells; HFLSs: human fibroblast like synoviocytes; PBMCs: peripheral blood mononuclear cells.
MAPK signalling | Study models | Consequences/summary | |||
In-vitro | In-vivo | Ex-vivo | Humans | ||
p38 MAPK isoforms | WT-mice | Cardiac dysfunction were restored by TG DN p38α MAPK | |||
Human monocytes Eucaryotic cells | Dog Monkeys | Humans | Increased inflammatory factors, cytokines and p38β MAPK were reversed by p38 MAPK inhibitor | ||
Cardio-myocytes | p38 MAPK inhibition attenuates cardiomyocyte growth in response to hypertrophic stimuli. over-expression of p38α MAPK reduced anti-apoptotic protein Bcl-xl expression, and p38 inhibition reduced stress-induced apoptosis |
||||
SD-rats | BPS treatment inhibits p38 MAPK, TNF-α, HIF-1α, MMP-9, BNP, ANP, myocardial cell apoptosis & delays the progression of DMHF in condition heart | ||||
SFMCs HFLSs PBMCs |
MK2 inhibitors decreases the expression of immune mediated inflammatory factors | ||||
Humans | p38 MAPK was activated in human heart samples of idiopathic dilated cardiomyopathy and ischemic heart disease. Suppressing it improves LV function, and myocardial infarction. |